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ABSTRACT
INVESTIGATION OF THE MECHANISM OF
ADR1 MEDIATED TRANSCRIPTIONAL ACTIVATION
by
Philip B. Komamitsky
University of New Hampshire, December, 1997

The purpose of these studies was to examine the mechanism of function of the
transcriptional activator ADR1 of yeast Saccharomyces cerevisiae. ADR1 is required for
the activation of the ADH2 gene, as well as genes involved in glycerol metabolism and
peroxisome biogenesis. ADR1 is a DNA-binding protein. It binds to a 22 bp palindromic
upstream activating sequence 1 (UAS1) element located 215 bp 5’ to the transcription start
site o f ADH2. Elements similar to UAS1 are found in promoters of all ADR 1-dependent
genes. ADR1 was shown previously to contain three transcriptional activation domains
(TADs): TADI (amino acids 76-172), TADH (263-357) and TADIH (420-462).
A novel activation domain, TADIV (residues 642-704), was identified in ADR1.
Analysis of different derivatives of TADIV indicated that its activation function is
principally localised to residues 698-704. In contrast to deletion of other ADR1 activation
domains, deletion o f activation domain IV from ADR1 severely compromised its ability to
activate ADH2 transcription.
ADR1 activation domains have been shown to directly interact in vitro with
ADA2 and GCN5 components of the ADA2 co-activator complex, and both ADA2 and
GCN5 are also required for full ADH2 derepression. In addition, direct interaction of
ADR1 TADs with TF1IB was observed, in which TADI displayed the strongest binding. A
point mutation in TFDB that reduced ADH2 derepression was found to result in decreased
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in vitro interaction of TJrJJU with TADI. These results suggest that THlK is a functional
contact for ADR1 activation of transcription.
Defects in ADA2, GCN5 and THJLB do not severely reduce ADR1 ability to
activate transcription, suggesting that there may be additional contacts that ADR1 makes
with the components of transcriptional machinery. In order to identify these proteins, I
examined which known components of the general transcription machinery are retained by
the ADR1 activation domains from yeast whole cell extracts. It was found that ADR1
transcription activation domain IV (TADIV) specifically retained core transcription factor
HD. Moreover, ADR1 could be co-immunoprecipitated with the TAF90 component of the
TF13D from yeast whole cell extracts. ADH2 activation by ADR I required the presence of
intact TFUD in vivo, suggesting that the physical interactions that were observed had
functional relevance.
We propose that multiple contacts made by the ADR1 activation domains to
different components of the general transcriptional machinery and to the ADA2 co-activator
complex contribute synergistically to the activation of the ADH2 gene. After facilitating the
first rate limiting step - for example, TFUD recruitment, other steps in the preinitiation
complex assembly become rate limiting, and even though transcription rate may have
already become significant, it is further increased by ADR I establishing new contacts to
TFHB and possibly other general transcription factors.
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G eneral Introduction.

The yeast Saccharomyces cerevisiae, when grown in the presence of glucose
and a mixture of other carbon sources such as disaccharides, ethanol, or glycerol, are
capable of selectively utilizing glucose only. This phenomenon is mediated by the
repression of genes whose products are involved in carbon catabolic pathways other than
glycolysis and is called “glucose repression”. Under repressed conditions, glucose is
fermented, and the end product is ethanol. Respiration in yeast is almost completely
inhibited under these conditions. Yeast cells are believed to acquire a selective advantage by
depriving other organisms of glucose [Ronne, 1995]. After glucose is depleted, yeasts can
then utilize the previously secreted ethanol while most other organisms would not be able to
use ethanol as a carbon source. The first enzyme in Saccharomyces cerevisiae ethanol
utilization pathway is ADH BE(alcohol dehydrogenase isozyme II) which catalyses
formation of acetaldehyde from ethanol.
Yeasts contain three well characterized alcohol dehydrogenase isoforms - cytoplasmic
ADH I and ADH II, and mitochondrial ADH ID. ADH I isoform is most abundant when
glucose is used as a carbon source. Its amount is reduced approximately 5-fold when
nonfermentable carbon sources, such as ethanol or glycerol are used [Denis et al., 1983].
In contrast, ADH II isoform is undetectable under glucose (repressing) growth conditions
and becomes a major isoform of ADH under nonfermenting growth conditions, i.e., it is
subject to glucose repression. One of the biochemical reasons for the yeast cell switching
from ADH I to ADH II is that ADH C has a lower

for ethanol [Wills, 1976]. ADH II

therefore converts ethanol to acetaldehyde more efficiently than ADH I under the
derepressing conditions, when acetaldehyde concentration in the yeast cell is very low
(Figure I).

1
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Figure 1 . Alcohol dehydrogenases in yeast metabolic pathways
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Genes that are subject to glucose repression include gluconeogenic enzymes,
Krebs cycle enzymes, components of the mitochondrial respiratory chain, peroxisomal
proteins and ADH n. Glucose repression is achieved both at the posttranscriptional and
transcriptional level. mRNA levels of some genes fluctuate by as much as 800-fold when
yeast cells are shifted from a repressing carbon source, such as glucose, to derepressing
conditions. In most cases this change is due to a dramatic increase in transcription,
although some effects on mRNA stability have also been reported. For instance, a major
determinant of the steady-state level of the mRNA encoding the iron protein (Ip) subunit of
succinate dehydrogenase of yeast is its rate of turnover. This mRNA is significantly more
stable in glycerol than in glucose media [Cereghino, 1996].
The molecular mechanisms underlying glucose repression are not completely
understood, and the signal transduction pathway effecting glucose repression is largely
unknown. The glucose itself or an early metabolite are not the triggers of the glucose
repression pathway. It has been suggested that the repression is triggered by the glycolytic
flux rather than by an early intermediate of glycolysis [Ronne, 1995].
The increase in the transcription rate of glucose-repressible genes occurs either by
removal of negatively acting factors or by action of positive factors, or both. The
mechanisms of transcriptional activation and repression in eucaryotes have been an area of
intensive research for a number of years. A very large number of genes had been implicated
in both processes. The genes participating directly in either process could be tentatively
divided in two subgroups: one including genes whose products interact with or
posttranslationally modify components of the general transcriptional apparatus and the other
including genes involved in the maintenance or modification of chromatin.
The widely accepted model of DNA-binding transcriptional activator function
proposes that these proteins, after binding to specific DNA sequences located in the

3
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proximity of the transcription start site of the promoters, strongly interact with some
components of the general transcriptional machinery and in turn bring them down to the
promoter. This facilitates the assembly of a protein complex which is capable of
transcription initiation. The minimal set of factors required for reconstituting accurate in
vitro transcription initiation by RNA polymerase II includes TFUA, TFHB, Tb'ilD,
TbilE, Tbilh, and RNA pol II [Wang et al., 1992]. Since it had been established that the
assembly of the initiation complex is an ordered process, i.e., every component joins the
complex at a designated stage, it should be possible to identify the rate-limiting step in the
process of the assembly of initiation complex on a given promoter. This step then should
be the primary target of an activator, although considering that the formation o f the
initiation complex involves the interplay of many factors, other scenarios are also possible.
In vitro studies with purified or partially purified components of general transcriptional
apparatus have shown that TFUD binding to DNA is rate-limiting in vitro for at least
some promoters, suggesting that this step represents a likely target for transcriptional
activators. The observation that many activators work synergistically suggests that more
than one step in the initiation complex assembly may be affected at once.
The sequential model of assembly of the initiation complex evolved in recent
years with the discovery of the RNA polymerase II holoenzyme [Koleske and Young,
1989]. The largest subunit of RNA pol II, encoded in yeast by the gene RPB1 has an
unusual C-terminal structure, which consists of head-to-tail heptad repeats of the prolinerich sequence YSPTSPS. Truncation of a part of these repeats results in the inability of
yeast carrying such a truncated RPBl to grow at 16°C. This feature was used to select for
mutations which would suppress temperature sensitivity and led to identification of a group
of nine genes, called SRBs. SRB proteins turned out to be physically associated with RNA
polymerase II in a protein complex which was named RNA polymerase H holoenzyme.
Further analysis of the holoenzyme revealed that not only SRBs, but also such previously

4
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identified general transcription factors as TFELH, TH1F, and TFIUB are associated in a large
complex prior to the assembly on a promoter. The direct implication of this observation in
the context of the activation of transcription is the substantial reduction of a number of steps
required for assembly o f the initiation complex. It also limits the number of steps that can
be affected by an activator. It was suggested that the recruitment of the holoenzyme to the
promoter is a one-step process [Carey, 1995].
DNA-binding transcriptional activators do not necessarily contact components of
the general transcription machinery directly. A number of proteins have been found to be
required for activated transcription but which are dispensable for basal transcription. Some
of these proteins were shown to physically associate with transcriptional activators and
were named co-activators or adaptors. These proteins are believed to mediate the activation
of transcription by bridging DNA-bound transcriptional activators and the components of
general transcriptional machinery. In yeast, co-activator function was attributed to the
ADA2 complex and in mammals a number of co-activators had been described, for example
CBP/p300, p/CIP, PCAF, TBP-associated factors (TAFs). Interestingly, it was found that
many of the co-activators posess histone acetyltransferase activity, suggesting that they
may mediate transcriptional activation in part by modifying chromatin structure at the target
promoters.
Nucleosomes (chromatin) present a significant obstacle for the transcription
factors in that it reduces the accessibility of DNA binding sites. A number of proteins have
been identified in recent years that are capable o f changing chromatin structure by
modifying nucleosomes postranslationally or physically rearranging them. The influence of
these factors on transcription can be both repressing or activating depending on what kind
of modification they bring about. The specificity of the effect of chromatin modifying
factors (i.e., how these factors locally modify chromatin at a particular promoter) is
achieved via interaction with specific DNA-binding proteins or via incorporation of these
factors into the general transcription apparatus. Protein complexes identified to date that are
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believed to be required for relieving the repressive structure of chromatin include the
SNF/SWI complex, some of the SPT factors [Bortvin et al., 1996; Dollard et al., 1994],
the RSC complex [Cairns et al., 1996], the ADA2/GCN5 complex in Saccharomyces
cerevisiae , and a number of similar protein complexes in Drosophila, mice and humans.
The nature of chromatin modification caused by SNF/SWI or RSC complex is unknown,
and probably does not involve covalent modification of histones. The SNF/SWI complex
was found to be tightly associated with the RNA polymerase II holoenzyme [Wilson et al.,
1996]. The GCN5 component of multiprotein ADA2/GCN5 complex is a histone
acetyltransferase, which is capable of acetylation of some of the lysine residues in the
histone N-termini. GCN5 is required for activated transcription of some, but not all, yeast
genes [Brownell at al., 1996, Candau et al., 1997]. Several other histone acetylases
(HATs) playing a role in transcription have been identified to date, for example TAF250,
CBP, pCIP [Mizzen et al. 1996, Yang et al., 1996]. Since the acetylation of histones
results in relieving repression caused by chromatin at some promoters, the removal of
acetyl residues from histones should result in the opposite effect. Indeed, a number of
recent reports have appeared linking histone deacetylation with transcriptional repression. It
was demonstrated that in yeast transcriptional repression by Ume6, a negative regulator of
genes involved in meiosis, is mediated by recruitment of the Sin3/Rpd3 complex. Rpd3, a
component of this complex and a histone deacetylase, can efficiently repress transcription
by itself when brought to DNA by fusing to a heterologous DNA-binding domain
[Kadosh, 1997]. Similarly, the mouse homolog of yeast Sin3, mSin3A, mediates
transcriptional repression by Mad/Max heterodimer, and mSin3 A is a component of large
multiprotein complex with histone deacetylase activity essential for effecting repression
[Hassig, 1997].
The research presented in this thesis is aimed at identifying the molecular
mechanisms by which activation of the ADH2 gene is achieved by its transcriptional
activator ADR 1.

6
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When glucose is removed from the growth medium and yeast are forced to grow
on a nonfermentable carbon source, ADH2 transcription is derepressed and ADH II activity
increases 500-fold [Ciriacy, 1975]. DNA sequences located -176 to -453 bp upstream of
the ADH2 transcription start site are required for regulated ADH2 transcription [Beier and
Young, 1982]. Two upstream activating sequences in this region, UAS1 and UAS2, were
shown to be required for full derepression of the ADH2 gene. The 22 bp palindromic
U AS1 had been shown to bind transcriptional activator ADR1, and UAS2 is believed to
bind an as yet unidentified factor which acts synergistically with ADR1 to activate ADH2
transcription (Figure 2).
ADR1 had been cloned [Denis et al., 1983] and sequenced [Hartshome et al,
1986]. It contains 1323 amino acids, and immunoprecipitation from yeast crude extracts
reveals that the protein has a MW of 150 kDa [Vallari et al, 1992]. Residues 1-16 o f ADR1
were found to be necessary for its nuclear localization [Thukral et al., 1989]. The DNAbinding domain of ADR1 is located in the N-terminus of the protein spanning residues 72176. This domain contains two zinc fingers of Q H j type (Figure 3), and mutation analysis
had shown that this region is essential for ADR1 function and DNA binding [Thukral,
1989]. Zinc fingers of Q H j type are also found in many DNA-binding proteins, for
example IMIIA [Miller et al., 1985], Spl [Kadonagaet al., 1987], Zif268 [Pavletich and
Pabo, 1991], and Krox20 [Nardelli et al., 1991]. More detailed analysis of the 72-176 aa
region suggested that besides being a DNA-binding domain this region also has a
transcriptional activation function. First, expression of ADR1 fragment 72-176 or 1-220 in
a yeast strain deleted for ADR1 resulted in ADH2 derepression [Cook et al., 1994].
Second, some of the mutations in this region resulted in a loss of its ability to activate
transcription from a heterologous promoter while apparently having no effect on DNA
binding [Cook et al., 1994a]. Taken together, these observations designated amino acids
72-176 as transcriptional activation domain I (TADI).

7
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Figure 2. ADH2 promoter structure
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Figure 3. Structure o f the ADR1 protein
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Deletion analysis of the ADR1 protein revealed two additional regions important
for activation of transcription that were localized to residues 262-288 (TADII) and 420-462
(TADIII) [Cook et al., 1994a, Young E.T., unpubl. observ.] (Figure 3). These fragments
of ADR1 were also able to activate transcription when fused to a heterologous DNAbinding domain. Deleting both TADH and TADIII from the full length ADR1 protein
resulted in the decrease of its activation potential. Deletion of any single one of these
domains, however, had very little or no effect on ADR 1-mediated activation. This result
suggested that TADII and TADIII have partially redundant functions in transcriptional
activation, presumably by affecting the same step in the activation process.
A substantial number of trans-acting factors other than ADR1 have been
implicated in the regulation of ADH2 gene expression (Figure 4). They can be divided into
two groups based on the effect on ADH2 expression. One is comprised o f genes whose
products are required for ADH2 derepression to occur, and mutations in these genes result
in complete or partial derepression defects on nonfermentable carbon sources. The second
group includes genes required for glucose repression, and mutations in these genes result
in improper expression o f ADH2 when glucose is present in the growth medium.
The first group includes ADR1, CCR1/SNF1, CCR4, CA Fl, and components of
the SNF/SWI complex. CCR1/SNF1 is a protein kinase whose activity is required for
derepression of all glucose repressible genes, CCR4 is a component of a large protein
complex whose other components are NOT1, NOT3 and a number of CAFs (CCR4
Associated Factors) and the precise role of this complex in transcription is not very well
understood [H.-Y. Liu, pers. commun.]. Many of the components of this complex,
including CCR4 itself, are well conserved among eucaryotes. SNF/SWI proteins are
involved in nucleosome rearrangements, and mutations in those genes lead to mild defects
in ADH2 derepression. Also required for full ADH2 derepression are some of the SPT
genes, such as SPT3 and SPT7 [Denis C. L., unpubl. observ.], whose function is believed
to be related to the TATAA box selection by TFUD.
10
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Figure 4. Regulation of the ADH2 promoter

complex

/

/+

ADR1

UAS2

Transcriptional
machinery

U A S1 L _ _ ^ A /T ^ E _ _ T A T M
215*

-100

Nucleosomes

(

SNF/SW I

y

I

complex

I

/

R eproduced w ith perm ission o f the copyright owner. Further reproduction prohibited w itho ut perm ission.

The second group of genes, mutations in which allow partial escape from glucose
repression, includes chromatin remodeling factor SPT6 (CRE2), another member of the
Spt group of proteins - SPT10 (CRE1) [Denis, 1984], and the gene partly responsible for
glucose repression at the ADH2 locus, REG I [Dombek et al., 1993]. Surprisingly, a set
of dominant mutations in the ADR1 gene was isolated that allowed partial escape from
glucose repression. All these mutations were amino acid substitutions in the narrow region
of the ADR1 protein, amino acids 227-239. Deletion of this region from ADR1 also led to
the partial escape from glucose repression. Since this region represented a consensus
sequence for cAMP-dependent protein kinase (cAPK) phosphorylation, and some of the
mutations leading to partial derepression of ADH2 drastically reduced the ability of cAPK
to phosphorylate this region, it was concluded that ADR1 activity is regulated
posttranslationaly and that cAPK phosphorylates and inhibits ADR1 activity under
fermentative growth conditions [Cherry et al., 1989]. However, additional experiments
[Denis et al., 1992] proved this not to be the case: yeast strains with no detectable cAPK
activity still were able to normally repress ADH2 on glucose, and a number of mutations in
the 227-239 region while allowing glucose-insensitive ADH2 expression did not affect the
ability of cAPK to phosphorylate this region. Based on these observations, as well as on
the fact that the 227-239 region when fused to a synthetic activator reduces the synthetic
activator ability to activate transcription [Cook et al., 1994], it was suggested that the 227239 region binds a repressor protein. Yet another region of ADR1 which allowed partial
escape from glucose repression as well as higher level of ADH2 expression under
derepressing conditions was mapped by deletion analysis to amino acids 282-330 [Cook et
al., 1994a].
Since ADR1 plays a pivotal role in ADH2 derepression, the transcriptional and
translational effects of glucose on ADR1 were extensively investigated [Vallari et al., 1992,
Cook, 1994a]. It was found that ADR1 protein level is reduced 5- to 8-fold in glucose
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versus ethanol grown strains, and AD Rl mRNA level is reduced approximately 2-fold.
Two-fold reduction of ADR1 mRNA level appears to result from the increased degradation
rate of ADR1 mRNA when yeast are grown in the presence of glucose, which is dependent
on a long 5 ’-untranslated region found in ADR1 mRNA. A D Rl mRNA half life in a strain
grown in glucose-containing medium is 45 min. compared a half life of 110 min. when
ethanol is present as the carbon source. The much more significant reduction of ADRl
protein level in glucose-grown cells is due to the reduction of ADRl protein synthesis, and
this effect is mediated by the region of ADRl encompassing amino acids 262-642 of the
protein. A recent report [Dombek et al., 1997] indicates that the reduction of ADRl protein
level under fermentative growth conditions is mediated via the cAMP-dependent protein
kinase pathway. An interesting observation made by Vallari et al., 1992 indicates that the
reduction o f ADRl level on glucose plays a functional role in regulation of ADH2
expression: an 8-fold dosage increase of ADR1-5Callele, resulting in the ADR1-5Cprotein
level on glucose similar to the ADRl protein level on ethanol in a strain carrying single
copy of ADRl gene, gives the level of ADH2 expression on glucose identical to that for the
single copy ADRl-containing strain on ethanol. This observation indicates that a
combination of post-translational modification or interaction with repressor protein and
reduction in the ADRl protein level contributes to the glucose repression of the ADH2
gene.
The analysis o f sequence features of ADRl TADs provided little clue as to the
mechanism of their function. No significant similarity to the activation domains of other
transcriptional activators from yeast or other eucaryotes was found. The comparison of
transcriptional activation domains from a variety of activators allows one to outline only
very general sequence features characteristic of transcriptional activation domains. One
class of these domains contains acidic residues interspersed with bulky hydrophobic amino
acids and is predicted to form amphipathic a-helices. However no conclusive experimental
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proof that these sequences actually form amphipathic a-helices exist. Some experimental
evidence [Sainz et al., 1997] indicates, that contrary to expectations, introduction of a helix - incompatible prolines into transcription activation domain of maize activator Cl
which is predicted to form an amphipathic a-helix, has no effect on C l function. Recent
experiments with the VP 16 activatior showed that the activation domain is most likely an
unstructured coil which is induced to undergo a significant structural alteration, presumably
to an a-helix, upon binding to the human TAF31 [Uesugi et al., 1997]. Two hydrophobic
residues and an aspartate were found to make direct contacts with hTAF31. The second
class of the transcription activation domains is comprised of glutamine-rich activation
domains. An example is the well described human transcriptional activator Spl.
Interestingly glutamine-rich transcriptional activators do not function in yeast, and the
reason for this failure to activate transcription is believed to be the absence of the
appropriate mediator of activation (co-activator) in yeast cells.
The focus of this dissertation is to elucidate the mechanisms of ADR I-mediated
activation of ADH2. In order to address this problem, the approach was taken to identify
proteins that physically interact with ADRl or its individual activation domains and to use
genetic techniques to study the effect of these proteins on ADH2 transcription in vivo. It
was found that A D R l TADs make multiple contacts to components of basal transcriptional
machinery and to coactivators. Using protein affinity chromatography and
immunoprecipitation techniques specific interaction of ADRl with coactivators GCN5 and
ADA2 and with basal factors TFTIB and TFUD was demonstrated. Deletion of GCN5 or
ADA2 genes negatively affected ADRl mediated ADH2 derepression. Targeted depletion
of a TAF90 component of the TFQD was found to completely prevent ADH2 derepression.
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Chapter I.

The identification of factors, interacting with the AD Rl activation
domains. Identification of T ranscription Activation Domain IV.

In troduction.
Three activation domains had been previously identified in the ADRl protein:
transcription activation domain one (TADI; amino acids 72-176), which overlaps with the
DNA-binding domain, TADII (amino acids 262-359), and TADIII (amino acids 420-462)
(Figure 3). The sequence of these activation domains did not reveal significant similarity to
any of the previously found transcriptional activators. TADIII amino acid composition is
fairly acidic (10 acidic residues out of 30 in the 421-456 region), and the structure of this
region partially agrees with the consensus sequence of the acidic activation domains of such
Saccharomyces cerevisiae transcriptional activator as GAL4, and viral activator VP 16
[Cook, 1994a]. A fourth region (642-1323) has been implicated for efficient peroxisomal
gene expression [Simon et al., 1995] and was presumed to contain a cryptic activation
domain. The precise function of the C-terminal region of ADRl had been, however,
unknown. In order to investigate the function of this region, we tried to identify other yeast
proteins that may interact with it using the two-hybrid system [Fields and Song, 1989]. In
our two-hybrid experiments we used the DNA-binding domain of the Escherichia coli
LexA protein fused to residues 642-1323 or 1-262 of ADRl and the GALA transcriptional
activation domain or synthetic transcriptional activation domain B42 fused to the yeast
genomic fragments (Figure 5).
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Figure 5. Two-hybrid system

PREY
Prey-bait physical interaction
Activation of
the reporter gene

Reporter gene

Abbreviations:
AD- activation domain
Prey- protein of interest fused to the activation domain
Bait- another protein of interest fused to the DNA binding domain
DBD- DNA binding domain
DRS- DNA recognition sequence
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M aterials and M ethods.

Yeast and Escherichia coli strains, growth conditions and enzvme assays.
Yeast strains are listed in Table 1. Conditions for growth of yeast cultures on
minimal medium or YEP medium, containing either 8% glucose or 2% ethanol have been
described elsewhere [Cook et al., 1994]. YD8 solid medium contained YEP supplemented
to 8% glucose and 2.5% agar.
All subcloning and DNA manipulations were conducted in Escherichia coli
D H 5a strain.
B-galactosidase assays were conducted on yeast extracts as described elsewhere
[Cook et al., 1994]. A D H II activity was assayed as described elsewhere [Denis, 1987].

Plasmids.
LexA202 plasmids are multicopy 2|i plasmids and have been previously
described [Ruden et al., 1991]. The 34 “reporter” plasmid is a 2fi based plasmid containing
eight LexA operator sites, controlling the LacZ gene [Brent and Ptashne, 1985]. The JG4-5
vector as well as yeast genomic library based on this vector have been described elsewhere
[Zervos et al., 1993]. The pPC86 vector and the library with GAL4 transcriptional
activation domain have been described elsewhere.
Plasmid pJKlOl used in the transcription interference assay contains GAL1
promoter with LexA operator inserted 3’ to the UASGand was constructed as described
[Cook et al., 1994a and references therein].
The construction of plasmids LexA ^-A D R 1-642-1323 and L exA ^-A D R l-l220 is described elsewhere [Cook et al., 1994a].
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T able 1. Yeast Strains

Strain

Relevant Genotype

EGY188

MATa ura3-52 his3 leu2 trpl LexAop-LEU2

938-9b

MATa ura3-52 his4 LexAop-LEU2

YEK20

MATa ura3 his3 trpl leu2 suc2 ade2 Iys2 taf25::TRPl pRS413-HA 1,-TAF25

yBY40-8’

MATaura3 his3 trpl leu2 suc2 ade2 lys2 taf90::TRPl pRS413-HAl3-TAF90

EGY188-aifl

MATa ura3-52 his3 trpl LexAop-LEU2 aifl::URA3

EGY188-gl

MATa ura3-52 his3 trpl LexA0p-LEU2 gcn5::URA3

PSY3I6

MATa ade2-I01 his3-A200 leu2-3, 112 lys2 ura3-52

PSY316-ada2

MATa ade2-101 his3-A200 leu2-3, 112 lys2 ura3-52 ada2::URA3

YMH130

M ATacycl his3M leu2 trpl ura3-52 sua7::LEU2 adel pRS313-SUA7

GMY26

MATa ade2-101 his3-A200 leu2-3, 112 lys2 ura3-52 gcn5::URA3

CY26

MATa ade2-101o his3-A200 Ieu2-Al trpl-A l lys2-801a ura3-52

CY57

MATa ade2-101o his3-A200 Ieu2-Al trpl-A l lys2-801a ura3-52 swi2::HIS3

612-Id

MATa ura3 his3 leu2 trpl ad h l-1 1

612-ld-al

MATaura3 his3 leu2 trpl adhl-11 ada2::URA3

612-1d-g1

MATa ura3 his3 Ieu2 trpl adhl-11 gcn5::URA3

612-ld-6a

MATa ura3 his3 leu2 trpl adhl-11 caf6::LEU2

1005-2-3b

MATaura3 his3 leu2 trpl sptlO::TRPl adh 1-11

787-6b

MATa adhl-11 adrl-l::A D R l-5c-TRPl ura3 Ieu2his3 trpl

40-lc

MATaura3 his3 trpl adhl-11 adrl-l::A D Rl-TR Pl
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Plasmid construction
Deletion of amino acids 642-704 from the full length ADRl was conducted as
described [Appendix A]. The resulting pBR322-41 IBaTADIV was cut with SstI and
SnaBI and ligated to pAK52, cut with the same restriction enzymes. The resulting
construct, pAK52ATADIV was then digested with BstEII, blunt ended with the large
subunit of Escherichia coli DNA polymerase I (Klenow), and subsequently cut with
Ncol. An ADRl fragment containing residues 1-642/704-1323 was ligated into pLexA2025, which was digested with Xhol, blunt ended with the Klenow enzyme, then cut with
Ncol. This procedure yeilded LexA^-ADRl aTADIV. Since in this construction the
junction between LexA and ADRl moieties differed from that of the original L exA ^ADR1, the new LexA^-ADRl with the identical sequence of the junction site was
constructed. To construct LexA^-ADRl fusion deleted for residues 675-704, ADRl from
pAK52 was PCR amplified with two primer pairs. Amplification with pair one gave ADRl
fragment 1-675 with Ncol at 5’ end and EcoRV site at 3’ end. Amplification with pair two
gave fragment 704-1323 with EcoRV site at the 5’ end and Sail site at 3’ end. Fragment
one was digested with Ncol and EcoRV, and ligated into pGEM3Zf that had been digested
with the same restriction enzymes. The resulting construct was digested with EcoRV and
Sail and the PCR product corresponding to the fragment 704-1323 (digested with the same
enzymes) was ligated into it. pGEM3Zf-ADRlA675-704 was cut with Ncol-Sall, and the
ADRl moiety was ligated into LexA202-5 digested with the same enzymes, resulting in
LexA ^-A D R IA675-704.
The full length A IF l gene was isolated as described below, and subcloned into
pUC19. The resulting construction was cut with Ncol and Sail, generating frill length
A IF l which was ligated into LexA202-5 vector digested with the same enzymes.
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The LexA^-AIFl containing only the C-terminal fragment present in the library
clone was constructed by cutting the library clone with EcoRI, and ligating the resulting
AIFl fragment into pLexA202-l cut with the same restriction enzyme.

Plasmid rescue from veast cultures
In order to obtain sufficient amount of plasmid DNA for cloning and sequencing
purposes, plasmids need to be rescued from yeast and transformed into E. coli. The yeast
strain containing the plasmid to be rescued was grown overnight in liquid culture in 2 ml of
the appropriate selective medium supplemented with 2% glucose. Yeast cells were collected
by centrifugation at 1000 g, and washed in 5 ml of TE. Washed cells were resuspended in
500

ml

TE buffer, 200 units of glucilase were added to the tube and yeast cells were

incubated with glucilase at 30°C for I hour in the shaker. Yeast cells were transferred to a
microcentrifuge tube, collected by centrifugation at 500 g, and gently washed in 1 ml TE.
Cell pellets were resuspended in 200

ml

Cell Resuspension Buffer (Promega Corp.,

Magic Miniprep), 200 ul of Cell Lysis Buffer (Promega Corp., Magic Miniprep) and 120
ml

10% SDS was added and mixed thoroughly. The suspension was boiled for 5 minutes,

then 300

ml

Cell Neutralization Solution (Promega Corp., Magic Miniprep) was added

and the mixture was kept at 4°C for 10 minutes. After centrifuging for 5 minutes at 6000 g
in a tabletop microcentrifuge, 600

ml

of the supernatant fluid were mixed with 1 ml of

DNA Binding Resin Slurry (Promega Corp. Magic Miniprep), and the protocol for
Promega Corp. Magic Miniprep was then followed. Five ml of rescued DNA solution was
used to transform Escherichia coli D H 5a strain.

Isolation of clones, sequencing and homology search
The LexA ^-A D R1-642-1323 truncations and AIF clones were rescued from
yeast cells as described above and sequenced by using the Sanger dideoxy method or by
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PCR-based cycle sequencing at the UNH Sequencing Facility. The full length clone of the
AIF l gene was isolated from the yeast genome cosmid 9315 containing a fragment of
yeast chromosome VIII.
Sequence comparisons were performed at the National Center for Biotechnology
Information using the BLAST Web service [Altshul et al., 1990].

Western Blotting
Western blot anslysis of LexA and B42 fusion proteins was performed as describedby
others [Draper et al., 1994]. To detect LexA fusions, rabbit polyclonal antibodies raised
against the LexA 1-202 fragment were used. Commercially available mouse monoclonal
12CA5 anti-HAl antibodies were used to detect HA 1-tagged B42 fusion proteins.
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R e su lts.

P a rt I.
Identification of the T ranscription Activation Dom ain IV of ADRl.

With the use of the two-hybrid system, we sought to identify proteins interacting
with A D R l. The transcriptionally inactive ADRl fragment spanning residues 642-1323
was fused to the LexA DNA binding domain [Cook et al., 1994a]. The vector expressing
this fusion protein was introduced into yeast strain EGY188 containing two reporters:
LexAop-LEU2 at the chromosomal locus and LexAop-lacZ on a 2(i-based high copy
vector. EGY188 with LexAap-LEU2, LexAop-lacZ and expressing LexA-ADR 1-642-1323
was unable to grow on Leu' selective plates and B-galactosidase activity in this strain was
<5 milliunits/mg protein. The strain was also white on plates containing X-gal, because of
the absence of B-galactosidase activity.
A yeast library, containing genomic fragments fused to the GAL4 transcription
activation domain, under the control of the ADH1 promoter, was transformed into this
strain. The total number of transformants obtained was lxlO 6. This number is sufficient to
represent every gene in yeast genome with a 99% probability.
After the transformation, yeast were plated on Ura'HisTrp'Leu' selective plates
and incubated at 30°C. The Ura' selection is used to maintain plasmid borne LexAop-lacZ,
His' selection maintains the LexA202-ADRl-642-1323 expressing plasmid, Trp' selection
maintains the library plasmid, and the only yeast cells that were able to activate the LexAopLEU2 reporter were able to form colonies on Ura'HisTrp'Leu' selective plates. Such
colonies were picked, plated on Ura'HisTrp'Leu' selective plates containing X-gal to test
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for the activation of the LexAop-lacZ reporter. Finally, colonies that were able to activate
both LexAop-lacZ and LexAop-LEU2 reporters were tested for the dependency of the
observed activation on the presence of library plasmid. The library plasmid containing the
TRPI selectable marker was lost from the cells by repeatedly streaking them to single
colonies on Ura'His' plates that do not select for the maintenance of the TRPI gene.
Colonies that lost TRPI were tested for the ability to activate LexAop-LEU2 and LexAoplacZ reporters. Surprisingly, in all colonies tested the activation of both reporters did not
depend on the library plasmid. Further analysis indicated that the ability to activate the
reporter genes was linked to the LexA ^-A D R 1-642-1323 containing plasmid. Rescuing
the L exA ^-A D R 1-642-1323 from the colonies that were able to activate LexAop-lacZ and
LexAop-LEU2 reporters and re-transforming them into the original strain containing both
reporters resulted in reporter activation.
Western analysis indicated that in all cases the truncation in the ADRl moiety of
the LexA ^-A D R 1-642-1323 has occurred (Table 2). The 56 isolates analysed were
subdivided into 9 groups according to the apparent size of the truncated derivative. The Bgalactosidase activities of the isolates were very close within each group, and the Bgalactosidase activity correlated with the truncation size, the longest truncation derivative
having the highest transcriptional activity.
Sequencing of 2 representative clones from each truncation group revealed the
premature stop codons corresponding to amino acids 675 (group 1), 679 (group 2), 687
(group 3), 692 (group 4), 694 (group 5), 698 (group 6), 701 (group 7), and 704 (group 8)
of A D R l. The corresponding S-galactosidase activities for each group are listed in Table 2.
Since the 642-704 fragment of ADRl was capable of activating transcription when fused
to LexA DNA binding domain, we tested the effect of deletion of this small region on the
transcriptional activation potential of the full length ADRl protein. Deleting the amino acids
642-704 resulted in the 20-fold reduction of the LexA ^-A D R l-1-1323 fusion ability to
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Table 2. Transcriptional activity of LexA202-ADRl-(642-1323) truncation
derivatives.

LexA-ADR 1-TADIV deriva

B-galactosidase
activity
(units/mg)

LexA ^-A D R 1-(642-704)

190

LexAjoj-ADR1-(642-701)

85

LexA^-A DRl -(642-698)

70

L ex A ^- ADR1-(642-694)

18

LexA202-ADRl-(642-692)

30

LexAj^-ADR1-(642-687)

24

LexA202-ADRl-(642-679)

8

LexA^-ADR 1-(642-675)

3

LexA202 alone

1.5

P-Galactosidase activities were measured as described in Appendix A. Values represent
averages of at least three separate transformants in the strain EGY188. S. E. values were
less than 20%. The LexA reporter was pl840 in all cases.
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activate transcription of the LexAop-lacZ reporter gene (Table 3). To study the effect of
amino acids 642-704 deletion on the ADRl transactivation of its physiological target, the
ADH2 gene, this region was deleted from the chromosomal copy of the ADRl gene by a
one step intergation procedure [Rothstein, 1991]. The AD Rl allele deleted for amino acids
642-704 had a 30-fold decreased ability to activate ADH2 transcription. The ADRl deleted
for TADIV was also unable to support growth of Saccharomyces cerevisiae on oleic acid
[C. L. Denis, pers. commun.] in agreement with the previously reported importance of Cterminal part of the protein for growth on this carbon source [Simon et al., 1995]. An
ADR1-5Callele deleted for residues 642-704 was also severely defective in ADH2 gene
activation. Adding back amino acids 642-675 did not restore the activity of LexA^-ADRl
fusion to the wild type levels (Table 3).
The ability of amino acids 642-704 to activate transcription when fused to a
heterologous DNA-binding domain as well as the importance of this region for the ADRl
function led us to designate the residues 642-704 as transcriptional activation domain IV
(TADIV).
The BLAST homology search of the Genbank database did not reveal strong
similarity of TADIV to any of the previously identified transcriptional activation domains.
The TADIV region had weak similarity to a region of yeast transcriptional activator ZMSI
(37.1% identity in 35 residues overlap, Figure 6). ZMS1 contains other similarities as well:
a highly homologous Zn-finger region with two C y ^ type fingers, and a region highly
resembling the ADRl 227-239 region (Figure 6). No data are available on the function of
the TADIV-like region in the ZMS1 protein.
The analysis of the TADIV sequence with the Protean program from DNA Star
software package gives conflicting secondary structure predictions depending on the
algorithm used. While residues 660 to 669 and 680 to 689 are predicted to form alpha
helices by both Gamier-Robson and Chou-Fasman methods, the region of amino acids
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Figure 6. Pairwise alignment of ADRl and ZMSl.

Results of SIM with:
Sequence 1: adrl, (1323 residues)
Sequence 2: zmsl, (1380 residues)
using the parameters:
Comparison matrix: BLOSUM62
Gap open penalty: 12
Gap extension penalty: 4

1. Zn-fingers of ASR1 and ZMS1
62.3% identity in 61 residues overlap; Score: 222.0; Gap frequency: 0.0%
adrl,
zmsl,

2

100 KLRSFVCEVCTRAFARQEHLKRHYRSHTNEKPYPCGLCNRCFTRRDLLIRHAQKIHSGNL
147 KPRPFLCPTCTRGFVRQEHLKRHQHSHTREKPYLCIFCGRCFARRDLVLRHQQKLHAALV

. C-region of ADR1 and its homology to a region of ZMS1

55.6% identity in 18 residues overlap; Score: 46.0; Gap frequency: 0.0%
adrl,
zmsl,

222 LKKLTRRASFSAQSASSY
336 MHKTKRHASFSASSAMIY
*

*

* * * * *

* *

*

3. TADIV region of ADR1 and its homology to a region of ZMS1
37.1% identity in 35 residues overlap; Score: 68.0; Gap frequency: 0.0%
adrl,
zmsl,

632 PAVSELNEYLDLFKNNFLPHFPIIHPSLLDLDLDS
786 PTTSQLNDYVTYYKEEFHPFFSFIHLPSIIPNMDS
*

★

* ★

*

*

*

*

*

* *

* *

The alignment shown was performed by the LA N V EW program. Only sequence
fragments with homology to ADR1 Zn-fingers, C-region and TADIV are shown.
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Table 3. The effect of deleting TADIV on ADR1 function.

ADHD
Relevant genotype

LexA ^-A D R l

B-galactosidase

R

units/mg protein
900

units/mg protein

LexA202-ADRl- A642-704

48

LexAjoj-ADRl- A642-675

100

DR

ADR1

<5

2000

A D R 1- A642-704

<5

60

ADH Et activities were conducted as described in Appendix A. P-Galactosidase activities
were determined as described in Appendix A in strain EGY188. S. E. values were less than
15%. L exA ^-A D R l, L exA ^-A D R l-A t^-T M and LexA202-ADRl-A642-675 represent
LexA-1-202 fused, respectively, to the full length ADR1 protein and to the full length
ADR1 protein whose residues 642-704 or 642-675 have been deleted. All ADR1 proteins
integrated at ADR1 chromosomal locus as well as all fusion proteins were expressed to
comparable levels in vivo (data not shown). ADR1, strain 40-Ic; ADR1-A642-704, same
as 4 0 -lc except adrl-l::ADRl-A642-704-TRPl.
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698-704, contributing most of the activation potential to the TADIV is predicted to form
alpha helix by Gamier-Robson algorithm and beta sheet by Chou- Fasman (Figure 7). The
distinguishing feature of this region is the abundance of bulky hydrophobic tyrosine
residues.
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Figure 7. Secondary structure preduction o f the A D R 1

T A D IV

Secondary structure prediction was performed wit the DNA Star software package module
“Protean”. ADR1 residues 642-704 were analyzed. Residue 1 in the figure corresponds to
residue 642 of ADRl.

■ Alpha, Regions - Gamier-Robson
■ Alpha, Regions - Chou-Fasman
□ Beta, Regions - Gamier-Robson
B Beta, Regions - Chou-Fasman
B Turn, Regions - Gamier-Robson
■ Turn, Regions - Chou-Fasman
D Coil, Regions - Garnier-Robson

■ Hydrophilicity Plot - Kyte-Doolittle

□ Alpha, Amphipathic Regions - Eisenberg
□ Beta, Amphipathic Regions - Eisenberg
Q Flexible Regions - Karplus-Schulz
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Part II.
Isolation of protein factors interacting with the ADR1
amino acids 1-262.

The two-hybrid screen for interacting proteins was also conducted with the
L exA ^-A D R l-1-262 fusion. This fusion is transcriptionally inactive in spite of the fact
that it includes TADI residues. The screen with JG4-5 vector-based yeast genomic DNA
library was conducted by Dr. Yueh-Chin Chiang. The expression of B42-(genomic
fragment) fusions in this vector is under the control of the galactose-inducible GAL1
promoter. This feature substantially alleviates the analysis of the dependency of activation
of the reporter gene(s) on the B42 fusion, since its expression can be turned off if glucose
is a carbon source and turned on if galactose is a carbon source.
Thirty seven yeast colonies were isolated from this screen whose ability to
activate LexAop-LEU2 and LexAop-lacZ reporter genes was dependent on the plasmids
carrying
B42-fused yeast genomic fragments. These plasmid clones were rescued from yeast cells
and organised into 4 groups based on the identity of the restriction digestion patterns.
Western analysis indicated that each group of clones expressed a protein of larger size than
the B42 alone, suggesting that an open reading frame fused to B42 is present in every case.
Retransformation of the rescued library clones into parental strain restored its ability to
activate reporter genes. The strength of interaction between L exA ^-A D R l-1-262 and
different library clones varied substantially based on the measured p-galactosidase activity
values (Table 4).
Library clones from each group were sequenced and BLAST search was
conducted with every sequence obtained. The results of the BLAST search are summarized
in the Table 4 . The genes were named AIFl through 4 (ADR1 Interacting
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Table 4. Proteins that interact with ADR1-1-262.

Protein

Interaction

Molecular

with

Weight

Homology

Interaction
with

kDa

LexA-AIFl

LexAADR1 (1-262)

(blue/white)

6-gal activity
170

92

YNL144c

No

AIF2/MAF1

120

66

None

Yes

AJDF3

160

45

None

No

AIF4

27

120

SNF2 family

Yes

JG4-5

2

N/A

AIFl

N/A

No

The four proteins that were shown to interact specifically with LexA-ADR 1-1-262 are
shown on the left. JG4-5 is the B42 activation domain without yeast inserts. The ability of
the B42-AIF fusions to interact with LexA-ADR 1 or LexA is given as a function of their
ability to activate LexAnp^LacZ (p34) reporter. Interaction with LexA-AIFl was monitored
by the ability to activate both LexA0p^LEU2 and LexAnp^LacZ (p34) reporters. [3Galactosidase activities were determined as described in Appendix A in strain EGY188. S.
E. values were less than 15%.
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Factors 1 through 4). AIFl is a highly acidic protein, AIF2 is identical to MAF1, a protein
whose mutations are implicated in missorting MOD5 (tRNA modifying enzyme) to the
nucleus [Murawski et al., 1994], and AIF4 is a SNF2 family member. I further
concentrated on the analysis of AIFl, which gave the highest P-galactosidase activity
values and thus quite likely was the strongest interactor with L exA ^-A D R l-1-262.
The AIFl gene encodes an 800 residues long protein with a very acidic Cterminus. The library clone isolated in the screen contained only 400 C-terminal amino
acids o f the protein. The full length A IF l clone was isolated from the chromosome V U I1262, in contrast to the B42-AIF1-C-terminal interacted with this ADR1 fusion cosmid 9315
as described in “Materials and Methods” . This clone was used to construct full length B42AIF1 fusion. This fusion failed to interact detectably with LexA^-ADR 1-rather strongly.
Interestingly, the LexA ^-A IFl fusion protein interacted in the two-hybrid
system with AIF2 and AIF4 library clones in terms of a blue/white screen. In contrast, the
four AIF proteins failed to interact with a number of other LexA fusions which we
examined. It was further determined that other L exA ^-A D R l-1-262 constructs which
differed solely in their sequences joined to LexA moiety or C-terminal to residue 262 were
incapable of interacting with any of the AIF proteins [Y.- C. Chiang, pers. commun.].
These data suggest that non-ADR 1 determinants of the original LexA^-ADR I - 1-262
fusion contributed significantly to its interaction with the AIFs.
The disruption of A IF l and AIF2 resulted in no apparent ADH2 phenotypes.
The analysis of the yeast genome database revealed a presence of close homolog of AIFl in
yeast (Figure 8). It is possible that the functional redundancy masks the effect of AIF l
deletion on the ADH2 locus.
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Figure 8. Similarity of AIFl to YNL144c
The alignment shown was performed by the BLAST program at the National Center of
Biotechnology Information.

Score = 648 (228.1 bits). Expect = 3.8e-86, Sum P(3) = 3.8e-86
Identities = 130/303 (42%), Positives = 190/303 (62%)
AIFl:
YNL144C:
AIFl:
YNL144c:

9 LKSPSSSSTCSMDEVLITSSNNSSSICLETMRQLPREGVSG
QINIIKETAASSSSH 64
LK
++S+ SM +■ + SS S+SI
+ ++
+
NI+ E
S
20 LKLSQTASSISM3DEFLCSSTTSNSILDSPLPKVTFNHIDSITDIOTNIMNEIVEPQSGV 79
65 AALFIKQDLYEHIDPLPAYPPSYDLVNPNKEVRFPIFGDTAPCPKSSLPPLYAPAVYELT 124
+++
IDP P PP YD NP+K +R+PI+PC S PP Y P-t-V T
80 DVDVADKNVLYCIDPYPVEPPCYDFANPSKVIRYPIYEHCRPCLTSVKPPSYTPSVEHYT 139

AIFl:

125 LISLKLERLSPYEISSNRSWRNFIIEINSTQLNFYHIDESLTKHIRNYSSGETKSEKEDR 184
++S+K+E+LSP+E +S+R W NFI++INSTQ+NFY ID+SLT+HI+NY G+
YNL144c: 140 WSMKMEKLSPFENASSRLWNNFXLQINSTQINFYSIDDSLTRHIKNYRGGEMFDHSH— 197
AIFl:

185 IHSDLVHRSDQSQHLHHRLFTLPTRSASEFKKADQERISYRVKRDRSRYLTDEALYKSFT 244
HS
SD+
L
T+S +F K D+ERI
+ RD ++L+DE L+KS++
YNL144c: 198 -HSKTA— SDRHHSARSLLNAFTTKSTYQFDKYDKERICGEIARDEHKFLSDERLFKSYS 254
AIFl:

245 LQNARFGIPTDYTKKSFVLRMSCESEQFLLRFSHIDCMIEWSMYLSIGISVSLDLEVREY 304
LQ A+ G+P DY+ + FVLRM CE +QFL++FSH+D++I W+MYL++GIS+SLDLE+RE
YNL144c: 255 LQCAKVGLPIDYSSRDFVLRMRCEGQQFLVQFSHVDELIYWAMYLNM3ISLSIiDLELREM 314
AIFl:

305 PDYRIVP 311
P YR VP
YNL144c: 315 PTYRSVP 321
Score = 192 (67.6 bits). Expect = 3.8e-86, Sum P(3) = 3.8e-86
Identities = 41/101 (40%), Positives = 61/101 (60%)
AIFl:

678 TLSCFSNIPYGTDDIKWKPAIKEISRRRYLRDSLKCIKPFLDSNDCLGKVTYIPVSGPTF 737
+L C N
++D KW PA + +SR+RY++DSL+CIKP + + +GK+I+ P
P F
YNL144c: 626 SLKC-GNKNQSSNDSKWAPATQLVSRKRYIKDSLRCIKPLTEDHPWVGKIIFKPALPPAF 684
AIFl:

738 ETSNK-IH-FSNRQS— LQKQKNHFLKGFIVGPTALIELNCK 775
ET+N I +S
S L
KNH+LK +IVG
++ K
YNL144c: 685 ETNNPPIRVYSGEDSTDLMHVKNHYLKPYIVGSCGFLKTGSK 726
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D isc u ssio n .
The search for proteins interacting with ADR1 fragments 1-262 and 642-1323
resulted in the identification of 4 proteins capable of interaction with the 1-262 region, and
revealed the fourth activation domain, TADIV, localized to the residues 642-704 of ADRL
No proteins interacting with the 642-1323 region were found.
The importance of the TADIV region for the function of the ADR1 is clear from
the effect the deletion of residues 642-704 has on the activation potential of ADR1 both at
the ADH2 locus and at the heterologous promoter of LexAop-lacZ reporter. Moreover, the
642-704 fragment of ADR1 by itself is capable of transcriptional activation when fused to a
LexA protein DNA binding domain. The deletion of this region from the full length protein
has a substantially stronger effect on ADR1 ability to activate transcription than the deletion
of any one of the previously identified activation domains [Cook et al., 1994]. It is
important to note, however, that the ADR1 fragment comprising only amino acids 1-642 is
capable of strong activation of transcription. In fact this fragment is a better activator than
full length ADR1A642-704. This observation suggests that C-terminal part of ADR1,
residues 704 to 1323, may partially block the activation by the three N-terminal activation
domains in the full length protein. Elements of sequence similarity of this region of ADR1
to self-repressive regions of some other yeast transcriptional activators [Poch, 1997]
supports this suggestion. The sequence analysis of TADIV reveals that it contains a number
of bulky hydrophobic residues in the 698-704 region, which by deletion studies is
suggested to be especially important for TADIV function. The impotance of hydrophobic
residues for function of other transcriptional activators has been described previously
[Leuther at al., 1993, Drysdale et al., 1995, Jackson et al., 1996]. These residues are
believed to participate in hydrophobic protein-protein interactions.
Four proteins were identified that contact a TADI-containing fragment of ADRl.
The analysis of effects of disruption of these genes on the ADH2 locus did not reveal clear
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effects. The reason for the absence of effects may be that other yeast proteins perform
redundant functions for those analyzed at the ADH2 locus. The presence of a protein in
yeast (Open Reading Frame YNL144C, chromosome XIV) with the sequence highly
similar to that o f AIF1 supports this notion. Further study of AIFs will be required to
understand their function.
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Chapter II.

ADR1 activation domains contact the histone acetyltransferase GCN5 and
the core transcription factor TFIIB.

In tro d u ctio n .

The presence of four activation domains in the ADR1 (TADI (76-172), TADII
(263-357), TADIII (420-462), and TADIV (642-704)) suggests that ADR1 may interact
with multiple transcriptional cofactors and/or components of general transcriptional
machinery. The observation that TADII and HI are functionally redundant [Cook et al.,
1994] suggests that some of these interactions may be with the same protein.
There are a number of potential targets for ADR1 activation domains. Core
transcriptional components including TBP, TFIIB, TFIIF, TFIIE, and TAFs have been
implicated in mammalian system as being direct contacts for transcriptional activators
[Choy and Green, 1993]. In addition to these general transcriptional machinery
components, other cofactors or coactivators may mediate the action of activators. The
ADA2 complex is one such coactivator complex. The ADA2 complex has been shown to
bind activators like GCN4 and VP16 [Bariev et al., 1995, Silverman et al., 1994] and to be
required for maximal transcriptional activity of several yeast activators [Berger et al.,
1992]. The ADA2 complex has been also shown to bind TBP, and it was suggested that
this complex acts as a direct mediator between activators and the general transcriptional
machinery. However, some yeast activators like GAL4 or HAP4 [Berger et al., 1992,
Pina et al., 1993] are only slightly or not at all affected by defects in the ADA2 complex.
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Recent experiments indicate that the GCN5 component of the ADA2 complex is a
histone acetyltransferase [Brownell et al., 1996]. Since chromatin structure at the promoter
had been shown to have a strong effect on transcription and the acetylation of histone Ntermini “loosens” chromatin and makes DNA more accessible, it was suggested that
activator recruitment of the ADA2 complex results in targeted histone acetylation which
allows for activated transcription to occur.
The analysis of chromatin structure at the ADH2 promoter found that one
nucleosome is positioned over the TATAA box and another on the transcription start site
under repressing conditions, and they are removed in an ADR 1-dependent fashion during
ADH2 derepression [Verdone et al., 1996]. The UAS1 sequence to which ADR1 binds is
not covered by a nucleosome under either repressing or derepressing conditions which may
explain why mutations in such chromatin remodeling proteins as components of SNF/SWT
complex have little effect on ADH2 derepression.
We found that mutations in AD A2 and GCN5 severely compromise the ability of
ADR1 TADs to activate gene expression. In addition, we demonstrate that there is strong
physical interaction between ADA2 and GCN5 and ADR1 TADs in vitro. TADIV binding
to GCN5 was shown to directly correlate with TADIV activation function. TADs I and IV
were also shown to make specific contacts to TFIIB. The interaction of TADI with the
TFHB is specifically impaired by a point mutation in TFIIB which in vivo leads to two
fold reduction of th&ADH2 derepression. These results suggest ADR1 TADs activate gene
expression in yeast through direct physical contacts with multiple proteins including
components of the ADA2 complex and the core transcriptional component TFIIB.
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Materials and Methods.

Yeast Strains.
Yeast strains are listed in Table I. Strain EGY188 was used for transformation
with plasmids expressing LexA ^-A D Rl fusion proteins. The ada2::URA3 and
gcn5::URA3 disruptions in strain PSY316 were a gift from L. Guarente, strains CY26 and
CY57 were provided by C. Peterson, strain YMH130 and all isogenic strains containing
mutant TFIIB alleles were provided by M. Hampsey.

Plasmid constructions.
Isolation o f LexA ^-A D R 1-642-704 and and its truncation derivatives, as well as
construction of LexA202-ADRl-D642-704 and LexA202-ADRl-D675-704 is described in
Chapter I of this thesis. All other LexA^-ADRl fusions are described elsewhere [Cook et
al., 1994a, Appendix A]. The construction of all GST fusions is also described in
Appendix A. Plasmid vectors used for one step gene replacements of ADA2, GCN5, and
ADH1 were described previously [Appendix A and references therein]. Construction of T7
in vitro expression vectors of different TFIIB alleles was conducted by PCR amplifying
TFIIB from a pM plasmid series provided by M. Hampsey, using primers which introduce
unique Bgffl and Ndel sites at 5’ and 3’ end of TFIIB open reading frame, respectively.
PCR products were digested with Bgin and Ndel, and digestion products were
subsequently ligated into the T7 expression vector pETI la [BioGen], which was
previously digested with BamHI and Ndel and treated with calf intestinal phosphatase. All
other T7 in vitro expression constructions were constructed as described elsewhere
[Appendix A].
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Transformations. Enzvme assays and Growth Conditions.
All yeast transformations were conducted by using the lithium acetate method [Ito
et al., 1983]. A D H II and B-galactosidase assays were conducted as described [Cook et al.,
1994]. Conditions for growth of cultures on minimal medium lacking uracil and histidine
or YEP medium containing either 8% glucose, 2% ethanol and 2% glycerol, or 3% ethanol
have been described elsewhere [Cook et al., 1994].

In vitro binding assay.
Conditions for in vitro binding assay are described in Appendix A.

Disruptions of ADA2. G CN5 and ADH I.
All disruptions were conducted according to the one-step gene replacement
protocol [Rothstein, 1991]. The disruption vector containing the GCN5 gene replacement
cassette was digested with Xhol and Sail and transformed into strain 612-Id, the
disruption cassette for ADA2 replacement was cut with BamHI and Xhol and transformed
into strain 612-Id, the disruption of ADH1 was done by transforming BamHI digested
pHH20 disruption vector into strain YMH130.

Plasmid shuffle.
YMH130 yeast strain deleted for the chromosomal copy of the SUA7 gene
(TFIIB) and containing an adhl::URA3 disruption and the plasmid-borne TFIIB allele on
a ///Si-marked single copy plasmid vector was plated on 5-fluoroorotic acid plates to select
for mutants in the URA3 gene. The YMH130 strain with adh2::ura3mttt was subsequently
transformed with the C//?A3-marked single copy vector containing SUA7. Transformants
were subsequently allowed to lose the H/55-marked S(M7-containing vector. The resulting
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strain was transformed with a set of mutant SUA7 alleles on HIS3-marked vectors.
Resulting transformants containing wild type SUA7 on a C/RAJ-marked vector and mutant
sua7 alleles on /fJSi-marked vectors were plated on 5-FOA plates to select for the loss of
wild type SUA7.

41

R eproduced w ith perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

R e s u lts .
In order to identify the factors through which the four individual ADR1 TADs act,
the effect of deleting different general transcription cofactors or adaptors on LexA-ADRlTAD transactivation has been analyzed. The results, described in detail in the Appendix A,
can be briefly summarized as follows: ADR1 TADI, H, III and IV were capable of binding
to the GCN5 and a GCN5 deletion resulted in 2 to 3-fold reduction of the ADH2 gene
derepression; ADR1 TADI and IV interacted with the core transcription factor TFIEB, and
interaction of TFIIB with TADI was substantially stronger than with TADIV.
We further analyzed the TFDB role in the ADH2 derepression. Random PCR
mutagenesis of SU A7gene conducted in Dr. Michael Hampsey laboratory yeilded a number
of TFIIB derivatives containing single or multiple amino acid substitutions and defective in
supporting growth at 37°C or 16°C. We have analyzed three of these mutant derivatives of
TFIIB for their effect on ADH2 transcription (Table 5). The sua7-9 allele (encoding
TFUB-9), containing E202G and F289S amino acid substitutions, was found to reduce
ADH2 derepression by two-fold. The in vitro binding assay conducted with this mutant
protein demonstrated (Figure 9) that its binding to TADI is severely diminished compared
to the binding of wild type TFIIB or another mutant allele which has no effect on the
ADH2 derepression. In contrast, TH1B-9 was unaffected in its binding to TADIV (Figure
9), suggesting that the observed decrease in the interaction with TADI is not due to the
gross structural change in the TFDB-9. The binding of other alleles of su a 7 , which
conferred reduced levels of the ADH2 derepression, to the ADR1 TADs is currently being
investigated.
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Table 5. Effect o f point mutations in SUA7 (TFIIB) on ADH2 derepression

Yeast Strains

ADH H activity
units/mg protein

WT

2400

TFIIB-9

1200

TFIDB-30

2200

TFHB-31

2500

ADH II activities were conducted as described in Appendix A. S. E. values were less than
20%. Values shown represent averages of at least three separate measurements for each
SUA7 allele. WT, strain YMH130; TFLLB-9 (mutations E202G, F289S), same as
YMH130 except pRS313-sua7-9; TFI1B-30 (mutations T200I, K314M), same as
YMH130 except pRS313-sua7-30; TFDB-31 (mutation L284Q), same as YMH130 except
pRS313-sua7-31
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F ig u re 9. Binding of ADR1 TADI and TADIV to mutant
variants of TFIIB.
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Binding studies between GST fusion proteins indicated and radiolabeled wild type ( T H
wt) and mutant (TFI1B-9, -31) variants of TFIIB were conducted as described in the
Appendix A. Amount of each GST fusion loaded on the gel is equivalent for all samples
loaded.
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Ih -

D iscu ssion .
ADR1 is the primary transcriptional activator of the ADH2 gene and has been
shown previously (Cook et al. 1994a) and herein to contain four separable domains capable
of activating transcription. These individual activation domains were found to be highly
dependent on a functional ADA2 complex for their ability as LexA fusions to activate a
LexA reporter system. Full length ADR1 fused to LexA still displayed, however, a
significant, albeit reduced, activation function when the ADA2 complex was inactive. The
activation domains in full-length LexA-ADR 1 must also be capable of binding targets in
addition to the ADA2 complex [Appendix A].
Since we observed that ada.2 or gcn5 deletions did not completely block ADR1
activation in all promoter contexts, it is likely that the ADR1 TADs make multiple contacts
in promoter specific ways. It is known that the TADs play different roles at different
promoters. TADI is solely required by ADR1 for maximal activation at the FOX2 and
FOX3 promoter, but not at either ADH2 or CAT1. TADEH, on the other hand, is required
for genes expression involved in glycerol mutations [Bemis and Denis 1988; Cook et al.
1994] for which TADH is less important. TADIV alone plays a crucial role for activation
of some unknown genes involved in peroxisomal biogenesis [Simon et al. 1995].
Therefore, in some promoter contexts a particular TADI interaction may be especially
strong or essential, perhaps as modulated by chromatin structure and/or other promoter
specific binding factors.
There are a number of potential targets for transcriptional activators. W e showed
that TFHB could bind TADs I and IV of ADR1 but neither TADs II or HI. TBP did not
display any selective binding to any of the four TADs. These results are to be contrasted
with that of GAL4 whose activation domain retains TBP but not TFIIB. The physiological
relevance of these interactions is not certain. For TADIV of ADR1 and for the GAL4
activation domain, mutations or deletions which clearly decreased their functions also
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directly reduced binding to TFIIB and TBP, respectively. Additionally, point mutation in
TFHB that reduced ADH2 derepression had a stong negative effect on TADI interaction
with TFIIB. This suports the biological importance of the interaction. It could also reflect
that a particular region of TADIV or GAL4 is sticky and that TFIIB or TBP represent
examples of proteins that could bind to the activator.
In any case, these results strengthen the case for examining a direct link between
ADR1 and TFIIB using more genetic or in vitro experimental approaches.
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Chapter III.

A D R l-m ediated transcriptional activation requires the presence o f an intact
TFIID complex.

Introduction:

In the Chapter I of this thesis and in our earlier report [Appendix A] we had
shown that individual activation domains of ADR1 contact TFIIB and histone
acetyltransferase GCN5 in vitro. However, the deletion of GCN5 and a point mutation in
the TFIIB which dramatically reduced its binding to ADR1 had only moderate effects on
the derepression of ADH2 gene, suggesting the existence of additional activation
mechanisms.
There are a number of potential targets for ADR1 activation domains among the
core transcription factors. TFIID, TFI1F, TFIIB, RNA polymerase II, TFHH and TFTTF.
have been implicated in mammalian and Drosophila systems as being direct contacts for
various transcription activators. For example, glutamine-rich activation domain of Sp I
contacts TFIID component dTAFl 10 [Hoey et al., 1993], VP16 interacts with TFIIB, TBP
and histone - like dTAF42/hTAF31, yeast GAL4 binds TBP and TFIIB [Gupta et al.,
1996, Wu e al., 1996]. In vitro studies have shown that activators have both qualitative
and quantitative effect on TFIID binding to the TATA box [Klemm et al., 1995]. It has
been also demonstrated that the TFIID binding step is first and rate-limiting in the assembly
of the initiation complex at many promoters [Shykind et al., 1997, Colgan et al., 1992],
making it a likely target for transcriptional activators.
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TFIID is a multimeric complex consisting of TATA box binding subunit TBP and
TBP associated factors (TAFs) [Poon et al., 1995]. Both TBP and TAFs show significant
degree of evolutionary conservation throughout the eucaryotic kingdom [Burley et al.,
1996, Moqtaderi et al, 1996], suggesting that TFIID quaternary structure may also be
conserved. Thirteen yeast TAFs have been cloned to date, with sizes ranging from 17 to
150 kDa [Tansey et al., 1997]. Most of these proteins are encoded by essential genes. The
precise role of TAFs in transcription is largely unknown. In vitro data suggest that these
proteins are required for activated transcription and that they can serve as direct targets in
vivo for activation domains of DNA-binding transcriptional activators of higher eucaryotes
[Hoey et al., 1993, Klemm et al., 1992, Sauer et al., 1996]. In vivo data, however,
indicate that yeast TAFs are not universally required for pol II transcription and are
dispensable for activated transcription of a number of yeast genes [Moqtaderi et al., 1996,
Walker et al., 1996]. Although encoded by essential genes, temperature sensitive alleles of
yTA Fl30/l45 and yTAF90 affect expression of only a small fraction of yeast genes
[Walker et al., 1996, Apone et al., 1996]. Similar results were observed when different
TAFs were eliminated from the yeast cell using a double shut-off method [Moqtaderi et al.,
1996].
We have found that ADR1 transcription activation domain IV can specifically
retain TFIID from yeast whole cell extracts and that overexpressed ADR1 coimmunoprecipitates with yTAF90. Moreover, transcriptional activation of the ADH2 gene
does not occur in vivo if the yeast cell is depleted of TAF90. These results suggest that
transcriptional activation of the ADH2 gene by ADR I is mediated through its contacts with
the TFIID complex.
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Materials and methods:

Strains and culture conditions:
Yeast strains are listed in Table 1. Strains 938-9b and yB Y40-8’ were used for
transformation with plasmids expressing ADR1 from the G3PDH promoter. Strains
ZMY60 and ZMY68 were a gift from Z. Moqtaderi and K. Struhl. For the TAF90 shut-off
assay, ZMY60 and ZMY68 were grown in synthetic media lacking uracil (SC-Ura),
supplemented with 5% glucose, until they reached 0 0 ^ = 0.3. At this time CuS04 was
added to a final concentration of 500 [iM, and incubation was continued for another 7
hours. Yeast cells were washed twice in SC-Ura supplemented with 3% ethanol, 500 (iM
C uS04, and incubated in this media for 6 hours. Aliquots were taken at 0, 1,2 and 6 hour
time points. For the preparation of yeast whole cell extracts yeast strains containing ADR1overexpressing plasmid were grown in synthetic media lacking leucine (SC-Leu),
supplemented with 3% ethanol, 3% glycerol or 5% glucose to the O D ^ = 0.7. All other
strains used in this work were grown in YEP supplemented with 3% ethanol, 3% glycerol,
to the ODgoo = 0.7.
All DNA manipulations and subcloning were done in E. coli D H 5a strain. GST
fusion proteins were expressed and purified from E. coli BL21 strain.
Plasmid constructions: The vector expressing full length ADR1 from G3PDH
promoter was constructed by cutting pJClOO [Cherry, 1988] with BamHI and Hind m and
isolating the fragment containing the entire G3PDH promoter and residues 1-649 of ADR1
and ligating it into pRS425 [Christianson, 1992] digested with BamHI and Hindin,
creating pPK46. pAK52 containing the entire ADR1 gene with approximately 1.5 kb of 3’
sequences, was cut with BstEII, blunt ended with Klenow enzyme, cut with Hind EH and
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the fragment containing residues 649-1323 of ADR I was isolated from the agarose gel.
pPK46 was cut with Sal I, blunt ended with Klenow enzyme, cut with Hind in and ligated
to the amino acids 649-1323 ADR1 fragm ent, creating pPK47 containing full length ADR1
under the control of the G3PDH promoter. pPK50 containing full length ADR1 deleted for
TADIV was constructed by cutting pPK47 with Nco I and Bsg I, isolating the vector
backbone from the agarose gel, cutting pPK4 [Appendix A] with the same enzymes and
ligating pPK4 fragment containing ADR1 residues 1-642-704-1200 into pPK47 backbone.
GST fusions of ADR1 TADs and Vpu were constructed as described in Appendix
A. Isolation of LexA fusions of ADR1 TADIV is also described in Appendix A.

Binding assays and immunoprecipitations.
GST fusion proteins were expressed and bound to gluthatione-agarose beads as
described in [Appendix A]. Yeast whole cell extracts were prepared from EGY188 cells
grown to a density of 5xl07, collected by centrifugation and disrupted by bead beating in 2
volumes of A300 buffer (20 mM HEPES. pH 7.6, ImM EDTA, 1 mM DTT, 300 mM
potassium acetate, 1% Triton and protease inhibitors). Washed gluthatione-agarose beads
were incubated with 1 mg of yeast whole cell extract protein in 250 ul of A300 buffer for 2
hours at 4°C on a rocking platform. Unbound proteins were removed by four rapid (<1
min) washes with 1 ml of A300 buffer and specifically bound proteins were resolved by
SDS-PAGE after boiling beads directly in sample buffer. Proteins resolved by SDS-PAGE
were transferred to PVDF membrane and analyzed by Western blotting as described
[Draper et al., 1994]. Antibody to TAF90 was kindly provided by M. Green, antibody to
R P B 1 subunit of RNA pol II was a gift from J. Jaehning.
Preparation of yeast extracts for immunoprecipitation were made according to
Woontner et al., 1991, with the following modification: DTT was omitted from the final
dialysis step.
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Immunoprecipitation.
Immunoprecipitation of triple HA 1-tagged TAF90 from yeast WCE was
conducted in immunoprecipitation (IP) incubation and washing buffer (25 mM BCP04, pH
7.6, 150 mM KC1, I mM NaPP„ 1 mM Na F, 5 mM MgCI2, 1 mM EDTA, 10% glycerol,
1% Nonidet P-40 and protease inhibitors cocktail). 20 microliters of packed protein A
agarose beads were incubated with 2|il of monoclonal 12CA5 antibody for 1 hour at 4°C
and in 250 pi o f IP incubation/wash buffer, washed once with the same buffer to remove
excess antibody and mixed with 2 mg of yeast crude extract protein in 500 pi of IP
incubation/wash buffer. Incubation was allowed to proceed for 2 hours at 4°C with
constant rocking. The beads were washed 4 times with 1 ml of the same buffer to remove
unbound proteins from the yeast extract, mixed with SDS loading buffer, boiled for 5 min.
and separated on a 8% polyacrylamide gel prior to Western analysis.

Northern analysis.
Total yeast RNA was isolated by the hot acidic phenol method [Ausubel, 1994],
and quantified by spectrophotometry (A,^). Approximately 40 ug o f total RNA per sample
was denatured with glyoxal and dimethyl sulfoxide and mixed with gel loading buffer
according to [Sambrook, 1989]. Denatured RNA samples were loaded in duplicate and
resolved on a 1.2% agarose gel, half of which was stained with ethidium bromide in 0.1 M
ammonium acetate to verify the equality of loading, and the other half was transferred to a
GeneScreen™ nylon membrane and hybridized to the 3’-32P-labelled ADH2
oligonucleotide probe GTTGGTAGCCTTAACGACTGCGCTAAC [Di Mauro et al.,
1993], according to the membrane manufacturer instructions, with the following
modification: all posthybridization washes were for 1 minute each.
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R e su lts.

TADIV specifically contacts TFIID.
We used affinity chromatography to determine if components of general
transcription factor HD interacted with transcription activation domains of ADR1. GST
fusions of TADI,

n, m , IV and Vpu bound to glutathione-S-transferase coupled beads

were incubated with whole cell extracts obtained from yeast strains expressing triple HA1tagged TAF90, TAF25 or BRF1. As shown in Figure 10, TADIV and to a lesser extent
TADI were capable of specifically retaining both TAF90-HA13 and TAF25-HA13, but not
BRF1-HA13. The GST-Vpu, -TADII, -TADHI fusions and GST alone bound none of the
tagged proteins. We subsequently examined if other components of TFUD were being
pulled down by TADIV and I. Yeast extracts were incubated with the same GST fusions
described above and the proteins which were retained were probed with antibodies to
different components of the TFUD complex: TAF130, TAF90, TAF60 and TBP (Figure
11). GST-TADIV fusion retained all of these components in amounts close to being
stoichiometric (Figure 11, lane 4). The RPBl subunit of Pol II, however, was not retained
by GST-TADIV. The most likely interpretation of this result is that TADIV retains the
entire TFIID complex. TADI displayed weak binding to TAF90 and did not retain any of
the other components of TFUD (Figure 11, lane 2), including TBP. GST-TADII displayed
weak binding to TBP as shown previously [Appendix A] and TAF130 (Figure 11, lane 6)
while GST-TADm did not bind any components of the TFUD complex (Figure 11, lane

7).
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Figure 10. ADRl TADI and TADIV interact with TAF90 and TAF25.

GST fusions were induced as described [Appendix A], bound to glutathione-agarose
beads, and incubated with yeast crude extracts from strains yEK20 containing TAF25HAlj, yBY40-8’ containing TAF90-HA13 and yKG1794 containing BRF1-HA13 as
described in “Materials and Methods”. Proteins were eluted from glutathione-agarose
beads by boiling and separated by SDS-PAGE. They were subsequently transferred to the
PVDF membrane and probed with 12CA5 mouse monoclonal antibody against the HA1
epitope. One hundred (ig of GST-TAD fusion was loaded in each lane. GST-TADI
contains residues 148-262 of ADRl; GST-TADII contains residues 262-359; GST-TADm
contains residues 420-462; and GST-TADIV contains residues 642-704.
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8

Figure 11 . ADRl TADIV retains TFUD from yeast crude extract.

GST fusions were induced as described [Appendix A], bound to glutathione-agarose
beads, and incubated with yeast crude extract from strain EGY188 as described in
“Materials and Methods”. Proteins were eluted from glutathione-agarose beads by boiling
and separated by SDS-PAGE. Proteins were then transferred to the PVDF membrane and
probed with the appropriate antibodies. The amount of GST fusion per lane is the same as
described in Figure 1.
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The ability of TADIV to bind TFIID correlates with the ability of LexATADIV fusions to activate transcription.

A set of GST-ADR1 truncation derivatives of TADIV that are modeled on LexATADIV derivatives which differ in their ability to activate transcription of a LexAop-lacZ
reporter construct was tested for their ability to retain TAF90-HA13 from yeast extracts.
LexA-TADIV C-terminal deletions activated LexAop-lacZ reporter to different extents
depending on the length of the ADRl moiety present in the fusion. LexA-ADRl-(642704), -(642-701), and -(642-698) retained significant transcriptional activity, whereas
shorter derivatives were less active (Table 2). As evident from Figure 12, the most active
TADIV truncation derivatives bound TAF90-HA13to the greatest extent, suggesting a
functional relevance of the observed binding. Similarly, TAF130, TAF90, TAF60 and
TBP were not retained by the transcriptionally inactive TADIV moiety represented in GSTTADIV-642-679 (Figure 11, lane 3).
We had shown previously that deletion of TADIV from the full length ADRl
protein drastically reduces its ability to activate transcription of ADH2 and of a LexAoplacZ reporter gene. Adding back part of TADIV which does not bind any of the TFIID
components does not restore the ability of LexA-ADRl to activate transcription: the 6galactosidase activities measured in strains expressing LexA-ADRl, LexA-ADR 1-A642704 and LexA-ADRl-A675-704 are 900,50 and 105 Units/mg protein respectively. Each
of these proteins was expressed to equivalent extents in the yeast cell (data not shown).
This result indicates that it is the region capable of binding TFUD that is required for ADRl
function.
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Figure 12. The ability of ADRl TADIV to interact with TAF90
correlates with TADIV ability to activate transcription.

The effect of C-terminal deletions of LexA-TADIV on its ability to bind TAF90-HA13.
GST-ADRl -TADIV derivatives of length as indicated in the Figure were expressed in E.
coli. and bound to glutathione-agarose beads as described in “Materials and Methods”,
extracts from yeast strain EGY188 were bound to the GST fusions, and the resulting
bound proteins were analyzed by Western analysis using 12CA5 antibody directed against
the HA1 tag, as described in Figure 1. 100 fig of every GST fusion was loaded on the gel.
Each GST fusion was expressed at comparable levels (data not shown; [Appendix A]).Bgalactosidase activities displayed are for LexA-TADIV derivatives in their activation of
LexAop-lacZ and are taken from [Appendix A].
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A D R l co-im m unoprecipitates with TAF90-HA13.

To address the question of in vivo association of full length ADRl with TF1ED
we tested if ADRl can be co-immunoprecipitated with TAF90-HA13. As shown in Figure
13, ADRl does co-immunoprecipitate with TAF90-HA13from the yBY40-8’ strain, but
not from strain 938-9b, that lacks HAl-tagged components of TFIID. It is worth noting
here that growth conditions do not have an effect on this observed interaction. ADRl coimmunoprecipitated with TAF90-HA13 when yeast cells were grown under either
repressing or derepressing conditions (data not shown). Although the ADRl protein in
both 938-9b and yBY40-8’ was expressed from a multicopy vector, the pattern and nature
of ADRl activation of ADH2 transcription remains the same when it is overexpressed
[Denis et al., 1981, Cook et al., 1994] suggesting that the association of overexpressed
ADRl with TAF90 represents a physiologically relevant interaction.

TAF90 is required for A D H 2 derepression.

TAFs have been implicated in co-activator function in in vitro systems by a
number of studies [Hoey et al., 1993, Wu et al., 1996, Sauer et al., 1996]. However,
recent results [Moqtaderi et al., 1996, Walker et al., 1996] indicate that yeast TAFs are
dispensable for transcription of a majority of yeast genes. Using a double shut-off system
designed to eliminate TAF90 [Moqtaderi et al., 1996], we tested if TAF90 is required for
ADH2 activated transcription. Yeast cells were depleted of TAF90 (Figure 14b) and then
tested for their ability to activate the ADH2 gene upon depletion of glucose. As shown in
Figure 14a, ADH2 derepression does not occur in a strain depleted for TAF90, but does
occur in an isogenic control strain. In contrast, the mRNA levels for ADRl and CCR4,
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Figure 13. ADR1 co-immunoprecipitates withTAF90.

Extracts from strain yBY40-8\ containing triple HAl-tagged TAF90 and expressing ADR I
from multicopy vector, and strain 938-9b, containing no HAl-tagged TAF and also
expressing ADR1 from the same vector, were incubated with 12CA5 antibody directed
against the HA1 tag, and the resulting immunoprecipitates were subjected to electrophoresis
on a 7.5% SDS-polyacrylamide gel. ADR1 and TAF90-HA13 were detected by Western
analysis: polyclonal antibody raised against ADR1 residues 208-231 was used for ADR1
detection, 12CA5 antibody was used for TAF90-HA13 detection. One hundred p.g protein
was loaded per each crude extract lane.
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Figure 14. ADH2 derepression does not occur in the absence of
TAF90.

Total RNA from strains ZMY60 (control) and ZMY68 was prepared, separated in agarose
gel and analyzed by Northern hybridization as described in the “Materials and Methods”
section. Both strains were shifted to SC-Ura, 2% ethanol, 500 |iM C uS04 after 7 hours
incubation in SC-Ura, 4% glucose, 500 fiM CuS04. Bottom panel: Identically loaded
duplicate gel was stained with ethidium bromide for rRNA (23S and 16S) according to
[Sambrook, 1989]. Previous experiments have determined that rRNA serves as a useful
standard for quantitating mRNA loadings [Cook et al., 1993, Vallari et al., 1992].
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another regulator of ADH2 expression, were essentially unaffected by depletion of TAF90
(Figure 14a). This requirement for an intact I'FilD complex in vivo for ADH2 activated
transcription confirms a role for TFDD in ADR 1-dependent activated transcription.
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D iscu ssion .

The results reported herein demonstrate an association of ADR1 with the TFI1D
complex that appears important for ADR1 activation of ADH2 . Five lines of evidence
suggest that ADR1 contacts 1'FllD in vivo: 1) TADIV of ADR1 binds TFIID isolated from
yeast cmde extracts; 2) the ability of derivatives of TADIV to bind TFUD correlates with
TADIV activation potential; 3) ADR1 co-immunoprecipitates with a known subunit of the
TFUD complex TAF90; 4) intact TFDD is required for ADR 1-dependent activation of
ADH2 in vivo, as depletion of the yeast cell of TAF90 prevents ADH2 derepression; and
5) deletion of TADIV from ADR1 severely compromises ADR1 function. This suggests a
model where ADR1 either aids recruitment of TFIID to the promoter, induces structural
reconfiguration of TFIID, or stimulates both processes, thereby allowing for transcription
to occur. However, our attempts to show that TADIV contacts TAF90 directly have been
unsuccessful to date (data not shown). There are several possible explanations for how
depletion of TAF90 could affect ADH2 without ADR1 contacting TAF90 directly.
Depletion of TAF90 may result in the release of other TAFs from the TFUD complex and
one of those TAFs may be the one(s) that directly contact TADIV. Studies of the human
yTAF90 homolog hTAFlOO reveal that hTAFlOO strongly interacts with a number of other
TAFs [Tao et al., 1997 , Dubrovskaya et al., 1996] and this interaction could be necessary
to keep these other TAFs in the TFIID complex. Alternatively, an as yet unidentified cofactor may mediate the interaction of TADIV with TAF90. It should be noted here that our
previous results [Appendix A] indicate that TADIV does not contact TBP directly. It is also
possible that TAF90 depletion may impose a new rate-limiting step on ADH2 derepression
unrelated to the ADR 1-dependent recruitment of TFIID. The latter possibility seems quite
unlikely though since TAF90 is dispensable for activated transcription of many yeast
genes.
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We found that ADR1 coimmunoprecipitates with TAF90 under both repressing
and derepressing conditions. It needs to be taken into account, though, that in the strain in
which the immunoprecipitation was done ADR1 was overexpressed from a multicopy
vector and that this overexpression allowed partial derepression of the ADH2 gene on
glucose to approximately 10% of the fully derepressed level on ethanol. These results
suggest that even in the presence of glucose, ADR1 can still make appropriate contacts at
the ADH2 promoter. It is possible that glucose repression affects not the ADR I-TFIID
interaction, but some other aspect of ADR 1-dependent ADH2 promoter function. One such
aspect could be ADR 1-dependent chromatin remodeling that occurs only under
derepressing conditions [Verdone et al., 1996]. On the other hand, glucose may negatively
affect ADH2 promoter function at least in part not through the ADR1, but via an ADR1independent mechanism. The observation that LexA-ADRl fusion protein functions as a
potent activator outside the ADH2 promoter context in the presence of glucose supports
this notion [Cook et al., 1994a].
We had shown previously [Appendix A] that ADR1 TADs directly contact GCN5
and TFUB and suggested that there should be additional targets for ADR1 activation
domains. TFIID now seems to be a very likely target for ADR1 function. It should be
noted, that TADIV of ADR1 is capable of strong binding of GCN5 and TFIID and that
sequence determinants important for both interactions are located in residues 695-704 of
TADIV.
The most widely accepted model describing how DNA-binding transcriptional
activators function is that these proteins recmit components of the general transcription
machinery to the promoter accelerating or allowing the formation of preinitiation complex
(PIC) or stabilizing the PIC at the promoter [Ptashne, 1997]. The requirement imposed by
this model on transcriptional activators is that they should physically interact with some of
the general transcription factors either directly or via intermediate factors, which are called
coactivators. Our results indicate that there may be several targets for ADR1 TADIV. A
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number of targets for activation domains of various Drosophila, mammalian and yeast
activators has been identified to date. They include a large number of core transcription
factors, such as TFilB, TFIID, TFHF, TFTIA, TFLLH, RNA Pol

n,

IFlLb, etc. [Ptashne,

1997, Zawel, 1995, Burley, 1996 and references therein], as well as proteins dispensable
for basal transcription in vitro (co-activators): for instance, CBP, SRC-1, or components
of ADA complex [Heery et al., 1997, Bariev et al., 1995]. Some of the co-activators have
histone acetyltransferase (HAT) activity, and the mechanism had been proposed [Grant et
al., 1997] by which targeted recruitment of HATs to the promoters by activators results in
removal or rearrangement of repressive nucleosomes, thus allowing formation of the
initiation complex. In this regard, one of the Drosophila TAFs, dTAF 250, posesses HAT
activity, and this HAT activity is conserved in its yeast homolog, yTAF130 [Bai et al.,
1997; Gopal and Weil, unpublished observation]. Recently, the direct role of acetylation in
modification of activity of some transcription factors had been suggested [Gu et al., 1997,
Bannister et al., 1997]. Regardless of what the exact mechanism of the observed effect is,
TAFs do seem to be required for ADH2 derepression. This observation distinguishes
ADH2 from many tested yeast genes, whose basal and activated transcription does not
seem to be dependent on TAFs [Moqtaderi et al., 1996, Walker et al., 1996],
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General Discussion.

RNA polymerase II transcription is a very complex process and is influenced by a
variety of regulatory stimuli. The mechanism of transduction of these diverse stimuli to the
general transcription machinery involves post translational modifications of transcription
factors as well as changes in their subcellular localization. The end result of the action of a
given signal is a change in transcription rate of one or more genes. The aim of the above
described research was to understand the mechanism of the ADR 1-mediated increase in the
transcription rate of the ADH2 gene in response to glucose. In particular the focus of this
research was understanding how the binding of the ADR1 to its cognate DNA recognition
sequence brings about the activation of the downstream gene.
It was found that the activation domains of ADR1 are capable of physically
contacting the components of general transcriptional machinery, namely TFTLB and TFIID,
as well as the components of the ADA2 co-activator complex. Additionally, functional
relevance of the observed physical interactions was supported by genetic methods. Point
mutations in TFHB that reduced its in vitro binding to ADR1 TADI decreased ADH2
derepression in vivo. Targeted degradation of the TAF90 component of the TFIID
abolished ADH2 derepression. Deletion of ada.2 or gcn5 also strongly affected A D Rlmediated transcription.
Interestingly, the extent of the effect of ada.2 or gcnS deletions or of a point
mutation in the TFHB on ADH2 transcription was much less than the effect of TAF90
targeted degradation, even though the pattern of binding of these proteins to ADR1 appears
to be similar. The possible reason for this may be that the TFUD binding step is strongly
inhibited at the ADH2 promoter and is the rate limiting step at this promoter in the absence
of ADR1. The recruitment of the TFIID to the ADH2 promoter by ADR1 requires TAF90,
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and after TFUD is recruited, other steps, such as TFDB entry into the preinitiation
complex, become rate limiting. Even though these steps also can be influenced by ADR I,
the “intrinsic” rate of TFllB entry into the complex is higher than that of the TFUD. This
hypothetically higher rate ofThilB recruitment without ADR1 participation allows
substantial transcription to occur even when ADRl-TFHB interaction is disrupted.
The disruption of the ADA2 complex may have effects that are less severe than
TFUD has on ADH2 transcription due to the partial redundancy of function. Recent data
[Brownell et al., 1996] indicate that the function of the ADA2 complex is to relieve
repressive chromatin structure by histone acetylation. Yeast TFUD also contains a histone
acetyltransferase (HAT) activity, namely the TAF130 component of TFUD is a histone
acetyltransferase [Gopal and Weil, unpublished observations]. So, even though ADA2
function is required for maximal activity of the promoter, it seems likely that repressive
nucleosomes can still be modified by some other HAT, one plausible example being
TAF130. An alternative possibility is that the activation of the ADH2 may occur without
the ADA2 complex function simply because this function is not crucial for this particular
promoter.
Interestingly, deletions of the spt3 or spt7 gene apparently results in a severe
defect in ADH2 derepression [V. Badarinarayana, C. L. Denis, pers. commun]. SPT3 had
been shown to associate with TBP [Eisenmann et al., 1992], and both SPT3 and SPT7
were found to be a part of the SAGA (Spt/Ada/Gcn5) complex [Grant et al., 1997]. One
possible model which may explain why some components of SAGA have a stronger effect
on ADH2 transcription than others is that the main function of SAGA at the ADH2
promoter may be not to modify chromatin (this function would be completely abolished by
the GCN5 disruption) but to function as an adaptor between ADR1 and TFIID. The SPT3
and SPT7 components of SAGA may be crucial for this adaptor function (Figure 15).
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Figure 15. Mechanism o f ADR1 function at the A D H 2 promoter
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ADRl A ctivation D om ains C o n tact th e H istone A cety ltran sferase
GCN5 a n d th e Core T ra n sc rip tio n a l F a c to r TFHB*
(Received tor publicacioa. June 20. 1996. and in revised form. September 20. 1996/
Y u e h -C h in C h ia n g , P h ilip K o m a r n its k y , D a n C h a s e t , a n d C ly d e L . D e m s§
From the Department of Biochemistry and Molecular Biology, University of Sew Hampshire.
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T h e y e a s t tr a n sc r ip tio n a l a c tiv a to r A D R lt w h ic h is
r eq u ir e d fo r ADS2 a n d p e r o x iso m a l g e n e e x p r e s s io n ,
c o n ta in s fo u r s e p a r a b le an d p a r tia lly r e d u n d a n t a c tiv a 
tio n d o m a in s (T A D s). M u tation s in ADA2 o r G C V 5, e n 
c o d in g c o m p o n e n ts o f th e ADA c o a c tiv a to r c o m p le x in 
v o lv e d in h is to n e a c ety la tio n , s e v e r e ly r e d u c e d L exA ADR1-TAD a c tiv a tio n o f a LexA-lacZ r e p o r te r g e n e .
S im ila r ly , th e a b ility o f th e w ild -ty p e ADRl g e n e to a c 
tiv a te a n AD£T2-driven p rom oter w a s c o m p r o m is e d in
s tr a in s d e le te d f o r ADA2 o r GCS5. I n c o n tr a s t, d e fe c ts In
o th e r g e n e r a l tr a n s c r ip tio n c o fa c to r s s u c h a s CCR4,
C A FI/PO P 2, a n d SNF/SWT d isp la y e d m u ch le s s o r n o
e ffe c t o n L exA -A D R l-T A D a c tiv a tio n . U s in g a n in vitro
p r o te in b in d in g a s s a y , ADA2 an d GC N 5 w e r e fo u n d to
s p e c ific a lly c o n ta c t in d iv id u a l A D R l T A D s. A D A 2 c o u ld
b in d TAD II, a n d GCN5 p h y sic a lly in te r a c te d w ith a ll
fo u r TA D s. B o th T A D s I a n d IV w e re a ls o s h o w n t o m a k e
s p e c ific c o n ta c ts to th e C -term inal s e g m e n t o f T F IIB . In
c o n tr a s t, n o s ig n ific a n t b in d in g to T B P w a s o b s e r v e d .
TAD rV d e le tio n a n a ly s is in d ic a te d th a t its a b ility to
b in d GCN5 a n d T F u B w as d ir e c tly c o r r e la te d w ith its
a b ility to a c tiv a te tr a n s c r ip tio n in vivo. A D R l T A D s a p 
p e a r to m a k e s e v e r a l c o n ta c ts, w h ic h m a y h e lp e x p la in
b o th th e ir p a r tia l r ed u n d a n c y a n d th e ir v a r y in g re
q u ir e m e n ts a t d if fe r e n t p rom oters. T h e c o n ta c t to an d
d e p e n d e n c e o n GCN5, a h isto n e a c e ty ltr a n s fe r a s e , s u g 
g e s t s th a t r e a r r a n g e m e n t o f n u c le o s o m e s m a y b e
o n e im p o r ta n t m e a n s b y w h ic h A D R l a c t iv a t e s
tr a n s c r ip tio n .

In Saccharomyces cerevisiae, the transcriptional activator
A DR! is required for expression of the glucose-repressible al
cohol dehydrogenase gene tADH2) under nonferm entative con
ditions (1). It also regulates genes required in glycerol metab
olism (2, 3) and peroxisome function and biogenesis (4, 5).
A D R l is a zinc finger, DNA-oinding protein that is 153 kDa in
size (6, 7). Its regulation of ADH2 under nonferm entative
growth conditions occurs by binding to U A Sl, a palindromic
site, located 110 bp1 upstream of the ADH2 TATAA sequence

* This research was supported by Mational Science Foundation
Grants MCB92-18T23 and MCB95-13412. National Institutes of Health
Grant GM41215, and HATCH project 291. This is Scientific Contribu
tion 1948 from the Mew Hampshire Agricultural Experimentation Sta
tion. The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement m accordance with 18 U.S.C. Section 1734 solely »
indicate this fact.
This research is dedicated to the memory of Michael von Ciriacy,
without whom it would not have begun.
4 To whom correspondence should be addressed. TeL: 603-862-2427;
Fax: 603-862-4013.
t Present address: NCI-Fredenck. Fort Detrick, Frederick. MD
21702.
‘ The abbreviations used are: bp. base paihaj; TAD, transactivation
T his p a p e r U a v a ila b le o n l in e a t h ttp ://w w w - jb c jC in f o r d .e d u /ib c /

(7). Sim ilar U A S l elem ents are located upstream o f other genes
th at A D R l controls (4. 8). Three regions o f A D R l have been
identified th at are required for its efficient activation oZADHZ
transcription: transcription activation dom ain 'TAD) I 7 6 172), TAD II f263-357). and TAD III (3 5 9 -5 0 9 X 2 . 9 .1 0 . 11*. A
fourth region <642-1323) has been im plicated for efficient per
oxisom al gene expression (5). The presence o f four transactivation regions suggests th at ADRl may m ake m ultiple protein
contacts to transcriptional cofactors and/or core transcriptional
components. The observation that TADs H and HI are func
tionally redundant (9) suggests that som e o f th ese contacts may
be made to the same protein.
There are a number o f potential targets for A D R l activation
domains. Core transcriptional components including TBP.
TFIIB, T F llF . TFHE, and TAFs have been im plicated in mam
m alians system as being direct contacts for transcriptional
activators i 12). In yeast, the GAL4 activation domain has been
show n to bind TBP but not TFIIB in vitro '13). In addition to
these core transcriptional factors, other cofactors or coacrivators may m ediate the action o f activators. The ADA2 complex is
one such coactivator complex. These proteins have been shown
to bind activators like VP16 and GCN4 (14. 15) and to be
required for maxim al transcriptional activity of several yeast
activators (16). However, some yeast activators like HAP4 and
GAL4 (1 6 ,1 7 ) are slightly affected or not affected by defects »n
the ADA2 complex. Because the ADAS complex has been also
been shown to bind TBP (14), it has been suggested th at the
ADA2 complex acts as a direct mediator betw een activators and
core factors. Recent evidence indicates th at GCNo is a histone
acetyltransferase '18). Activator recruitment o f the ADA2 com
plex may result, therefore, in histone acetylation th at would
help relieve a repressive chromatin structure.
Genetic studies have implicated several general transcrip
tional factors as possibly mediating A D R l activator function.
The CCR4 and CAF1/POP2 proteins, components o f a muitisubunit transcriptional regulatory complex, are required for
proper expression of a number of yeast genes including ADH2
(1 9 -2 2 ). In previous studies we have analyzed the dependence
o f A D R l TADs on the CCR4 and C A Fl cofactors, but ccr4 and
cafl defects generally had only 2-3-fold effects on A D R l TAD
function (22, 23). Moreover, ccr4 and cafl defects can affect
ADH2 expression under conditions when A D R l is inactive >19.
22). T he SNF/SWI factors involved in nudeosom al remodeling
(24) are also known to be important to ADH2 derepression
(25-27). Consistent with the role of the SNF/SW I factors in
ADH2 expression are the presence o f two repressing nucleo
som es at the ADH2 promoter that are removed in an A D R ldependent manner during ADH2 derepression (28). N either of
the repressing nucleosomes in the ADH2 promoter occupies the

domain: GST, glutathione 5-cnuisferase; PAGE, polyacrylamide gel
electrophoresis; KAc, potassium acetate.
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A D R l Contacts ADA2, GC.V5, a n d TFIIB
Table I
Yeast strains

Genotype

Strain

EGY1S8
eEGY188-gl
PSY316
PSY316-ada2
GMY26
CY26
CY57
612-ld
612-td-al
612-ld-gl
6l2-ld*6a
1006-2-3b
787-6b
40-lC

\L\Ta ura3—
52 hi/3 trpl LexAop-LEL'2
Seme as EGY188 except gcno ••URA3
MATa ode2-lQl his3-3200 Ieu2-3J12 lys2 un3S2
Same as PSY316 except ada2 URA3
Same as PSY316 exceptgcno--URA3
MATa ura3-52 fus3-320O trpl-<
11ieu2-\2 lys2-901a ade2~I0!o
Same as CY26 except sun2 : ■
HIS3
MATa ura3 his3 Uu2 trpl adhl-l I
Same as 612—Id except ada2 '■'URA3
Same as 612-ld except gcno ■■URA3
Same as 612-ld except cafS :LEV2
MATa urej kis3 leu2 trpl sptlO- TRPl adhl-ll
MATa adhl-ll adrl-l ADRl-S'-TRPl ura3 leu2 his3 up I
MATa urtx3 his3 trpl adhl—
l l adrl—
lADRl-TRPl

U A S i site to which ADR1 binds (28), which m ay explain the
lim ited e je c t s o f snflswi mutations on ADH2 derepression
(25, 27).
In this paper we continue our investigation into the factors
required for A D R l function. We report th at mutations inADA2
and GCN5 severely compromise the ability o f A D R l TADs to
activate gene expression in uiuo. In addition, we demonstrate
th at there is physical interaction betw een ADA2 and GCNo
and the A D R l TADs in vitro. TAD IV binding to GCK5 was
shown to directly correlate with TAD IV activation function.
TADs I and rv were aiso shown to make specific contacts to
TFIIB but not to TBP. These results su ggest that A D R l TADs
activate gene expression in yeast through direct physical con*
tacts with m ultiple proteins.
EXPERIMENTAL PROCEDURES
Yeast Strains

Yeast strains are listed in Table L Strain EGYI88 was used for
transformation with plasmids expressing LexA-ADRl fusion proteins.
The ada2::(jRA3 and gcn3::URA3 disruptions in strain PSY316 were a
gut from L Guarante, and strains CY26 and CY57 were provided by C.
Peterson.
Plasmid Constructions
LexA-ADRl Fusions—Ail LexA-contaming plasmids encoded full*

length LexA-1-202) except for LexA-ADRl-( 1-220). which contained
only the DMA binding domain of LexA <
residues 1-87 1. The LexA fusion
proteins were expressed from an ADHI promoter and were expressed in
yeast on a 2 t* plasmid containing die selectable marker CRA3 >9).
Plasmids containing LexA-ADRl-(1-1323) (full-length), LexA-ADRlvl-220)-TAD I. and ADRl-'262~359)-TAD [I have been previously de
scribed (9). LexA-ADRl-<420-462)-TAD III was constructed following
polymerase chain reaction using oligonucleotides designed Co generate
.Vcol and Xhol sites at the ends of the 420-462 fragment of ADRl
(oligonucleotides: S'-GTCATGCCATGGATCCTGATTTCGTCGAT-S*
and 5*-GCGTACTCGAGAAGmTGACGTGGCGOTAG-3*). The result
ant ADRl polymerase chain reaction product after cleavage with iVcoI
and Xhol was ligated into the iVcoI-XhoI sites of plasmid LexA-202-5 (9)
to generate LexA-ADRl-t420-462). LexA-ADRl4642-704)-TAD IV and
its deletion derivatives were derived from plasmid LexA-ADRl-(6421323) (9) by selectingfor LexA-ADRl 4642-1323) derivatives that could
activate the LexAop-LEU2 reporter in strain EGY188- All Leu2* pro
tetrophs analyzed were the result of alterations in the amino add
region 672-704 of ADRl that created truncated LexA-ADRl4642-704)
derivative proteins. Each of these proteins was expressed to a compa
rable extent as analyzed by Western analysis. Sequencing of each of
these resultant plasmids revealed stop codons in the DMA sequence
that were in agreement with the relative size of each of the LexA-ADRl(642-704) protein derivatives.
GST-ADR1 Fusions—The construction of GST-ADRl-Cl-262)-TAD I
was conducted by removing residues 1-262 from pJClOO (29) with iVcol
and .'E m /I I and ligating into pGEM-5IT- } cut with Ncol and EeoRV. The
resultant plasmid was then digested with Ncol and Sail and ligated
into .Vcol and Xhol sites of pGEX-KG (30) to create GST-ADR141-262).
GST-ADRl-263-359)-TAD II was constructed by inserting a BamHIS a il fragment of LexA-ADRl -TAD R into 3cm HI-Sail sites of pGEX-

KG. GST-ADR14420-462J-TAD III was constructed by inserting a
Xcol-HLndUl fragment of LexA-ADRl-TAD HI into the Ncoi-HindUI

sites of pGEX-KG. In the construction of GST-ADRl-TAD IV’-*642-704),
a DNA fragment from. LexA-ADRl-TAD IV-<642-704) was synthesized
by polymerase chain reaction with oligonucleotides 5 *-GOITCACCATTGAAGGGC-3' and 5'-CCGAATTCACAAGATTTGATAGTGCTCG-3'
designed to create Smal-EcoRl restriction sites at the ends. This frag
ment was ligated in 5moI-£coRI sites of pGEX-KG that had been
precut with BamHI, blunt ended with the large subunit of Esehenchia
coli DNA polymerase (Klenowj, and religated. For all other GST-ADRlTAD IV truncations, a SmnI-£coRI fragment from the LexA-ADRl TAD IV truncations was inserted into SmcI-£coRI sites of pGEX-KG
whose BamHl site had been filled in with Klenow to create the proper
reading frame. GST-Vpu contains the hydrophilic segment of the HIVI
protein Vpu '.residues 33-81) and was a gift of B. Kemp (St Vincent's
Institute of Medical Research. Melbourne. Australia;. GST-CAFl and
GST-CCR4 were provided by J. Meegan and S. Fontaine (University of
New Hampshire. Durham, NH). respectively.
Transformations, Enzyme Assays, and Growth Conditions

All yeast transformations were conducted by using the lithium aceeate method '31). ADH II and d-galactosidase enzyme assays were
conducted as described (9). Conditions for growth of cultures on mini
mal medium lacking uracil and histidine or YEP medium containing
either 8% glucose, 3% ethanol or 2% ethanol. 2% glycerol have been
described elsewhere (9*.
In Vitro Binding .Assay

GST fusion proteins were expressed and bound to glutathione-agarose beads <Sigma; in binding buffer <1 * phosphate-buffered saline.
Tnton). Beads were washed 4 times with binding buffer and then
incubated for 60 min at 4 *C in A300 buffer (20 mM HEPES. pH 7.6. 1
mM EDTA. 1 mM dithiothreitol. 20% glycerol. 300 mMpotassium acetate
{KAc;, 1% Triton; containing I mg'mi E. coli extract and 40-200 r.g of
[“ SImetiuomne-labeled in vitro translated proteins. In vitro transla
tion of T7 fusion proteins was carried out by using the TNT-coupied
transcription translation system (Promega). Unbound proteins were
removed by four washes with A30O buffer, and specifically bound pro
teins were analyzed by SDS-PAGS after elution with 50 mM reduced
glutathione in 50 mMIris, pH 8.0, or by boding beads directly in sample
buffer. High salt washes of radiolabeled proteins bound to GST fusions
were conducted as described above except that A300 buffer was changed
to the appropriate KAc concentration (600. 900. or 1200 mM). The
T7-GCN5. -ADA2, and -ADA3 plasmids were gifts of L Guarente (MIT).
T7-TFUB was provided by M. Hampsey (University of New Hamp
shire). T7-TBP was <t gift of S. Johnston (University of Texas South
western Medical Center), and T7-N-TFHB and T7-C-TFIIB were pro
vided by R. Pollock (Arias Pharmaceuticals).
Deletion o f Residues 642—
704 of ADRl at Its Chromosomal Locus

The ADRl moiety in pBR322-4llB (32) was cut with BgDl *'bp
4-1,923) and BsrBI (bp -2,119). and the overhangs were filled in with
Klenow and religated with 74 DNA ligaae. The resultant plasmid was
digested with Sael (bp r 1,713) and BomKI (bp -3.200). and the 1.5-kb
ADRl fragment containing the deletion was ligated to pCDIO *9} pre
viously treated with Sac I and 3am HI. To improve the efficiency of
integration, the Sam HI fragment of pCDIO (bp 3,200-3.609) was added
back to the pCDIO plasmid, which contained the BgHl-BstBl deletion.
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T a b l e U,

The effect of ada2, gcnS, and snf2 deletions on the ability of LexA-ADRl fusions to activate a LexA-lacZ reporter

3-Gaiatxostdase activities (units/mgj represent averages of at least three separate transformants measured in isogenic strains PSY31S 'wild
type;. PSY3l6-uda2 <ada2), and GMY26 {gcnSi and the isogenic strains CY26 (SNF2), and CY5? snj2) using the LexA-lacZ 1S40 reporter gene os
previously described (9). The 1840 reporter plasmid contains a single LexA operator site upstream of the GALI-lacZ promoter. LexA-ADRl fusions
are described under "Experimental Procedures." TADs I and II were defined as activation domains previously (9.10); TAD n i previously localized
to residues 359-506 (9) was more precisely located to 420-462 (J. Saario and T. Young, personal communication); and TAD IV was denned as
shown in Fig. 3 and Table V. Strains were grown on minimal medium la c in g uracil and histidine and supplemented with 8%glucose as previously
described >9). LexA fusions were expressed to comparable levels as determined by Western analysis. The LexA-ADRl fusion proteins were
approximately 50-fold more abundant than single copy ADRl. S.E. values were less'thaa 20% in each case.
3-GalactostdaM activity

L«xA fasten
ada2

gens

SST2

uniiMJmg

ADRl-* 1-1323) /full-length}
ADR1-U-22QI-TAD I
ADRl-< 262-359VTAD II
ADRl-/420-462)-TAD HI
ADRl-642-704)-TAD rV
LexA alone

1900
23
420
46
150

100

<2

<2

<1
<1
1.3
4.3

The resulting construct was cut with 5/taBl and transformed into strain
500-16 to site-spedficaily integrate at the adrl-I locus. Identification of
single integrants and their subsequent analysis were conducted as
described previously '33).
RESULTS
The ADA2 Complex Is Required for ADRl Activation o f Tran
scription—ADRl contains three separate transcription activa

tion domains, and a fourth activation region has been im pli
cated :n residues 642-1323 (5, 9). TAD IV was subseq uently
more precisely localized to residues 642-704 (see below ). In
order to identify the factors through which the four individual
A D R l TADs act, the effect o f deleting different general tran
scription cofactors or adaptors on LexA-ADRl-TAD transacdvadon has been analyzed.
D eletion o f the ADA2 or GC.Vo gene dramatically reduced
the ability o f LexA-ADRl (full-length) to activate the LexA-lacZ
reporter gene (Table II). Moreover, the activation function of
each LexA-ADRl-TAD w as shown to be highly depend en t on
functional ADA2 complex components (Table CD. The expres
sion o f the LexA-protein fusions was unaffected by d eletion s in
ADA2 or GCNS as analyzed by Western analysis (d ata not
shown;. An ada2 or gcrtS deletion does not uniformly affect all
LexA transactivators (16. 17), and its reduction o f A D R l acti
vation ability (20-50-fold effects) appeared to be one o f the
m ost severe o f the several activators previously tested (17, 34}.
The observation th at both an ada2 and a gcnS deletion affected
LexA-ADRl-TAD function is in agreement w ith previous re
su lts dem onstrating th at inactivation of any component o f the
ADA2 complex reduces the function of the complex (17, 35). In
contrast to these results, the deletion of the SNF2/SWI2 gene,
which is known to severely reduce the activity o f GAL4 and
other LexA transactivators (36), displayed little or no effect on
A D R l TAD function (Table II). Similarly, deletion o f th e SNF5
and SWIl genes, two other components o f the SNF/SWT com
plex, resulted in little or no diminution o f A D R l TAD function
(data not shown). In addition, we have previously show n th at
m utation o f either CCR4 or CAFl, two components o f a m ulti
subunit transcription complex required for maximal ADH2 ex
pression, had generally only 2-3-fold effects on LexA -AD R lTAD activation o f a LexA-lacZ reporter (22. 23).
In order to verify the physiological relevance o f the require
m ent o f the ADA2 complex for ADRl activation, we exam ined
w hether the activation ability o f the wild-type full-length
A D R l protein at its normal cellular concentration w as also
compromised. We found th at deletion of the ADA2 or GCNS
gene dram atically reduced the ability of A D R l to activate an
ADH2-lacZ reporter under derepressed growth conditions (T a
ble III). The derepression o f the ADH2-lacZ reporter gen e has

53
ND*
7.5
LS

5.0
<2

1100

S*D
230
41
160
<2

1300
ND
220
22

140
<2

been shown previously to be strictly dependent on A D R l f7 \
and ADH2-lacZ contains all of the promoter sequences neces
sary for complete derepression of ADH2 (37). In contrast, an
ada.2 or gcn5 deletion had at most 2-fold effects on the sim ilar
CYCl-lacZ reporter gene, which is under th e control of the
H A P l and HAP2/3/4 activators (Table HD. Relatedly, the
LexA-HAP4 transactivation ability is not affected by ada2 or
gcno deletions (16, 17).
We subsequently analyzed the effect o f ada2 and gcno de
fects at the wild-type ADH2 promoter. ADH2 expression was
reduced 2.5-fold by an ada2 deletion under ethanol growth
conditions (Table IVV Sim ilarly, the ability o f an ADRlc ailele
to bypass glucose repression and allow increased ADH2 expres
sion w as reduced about 3-fold by an ada2 defect (Tabic IV). The
ada2 allele, in contrast, had no effect on spflO-enhanced ADH2
expression under glucose-repressed conditions, which occurs in
an ADRl-independent manner (Table IV) (19). A gcno ailele
also reduced die ability o f the ADH2 gene to derepress / Table
IV). These results indicate that the ADA2 com plex is required
for ADRl-dependent activation o f transcription in different
promoter contexts.
Components of the ADA2 Complex Physically Interact with
Each o f the TADs ofADRl—Sitice the activation ability of the

AD R l TADs was strongly ADA2 complex-dependent, we tested
if this dependence was the result o f ADA2. GCN5. and ADA3
proteins making direct contacts w ith A D R l TADs. GST fusions
to individual ADRl TADs w ere constructed (Fig. LA), and their
ability to bind to [^Slmethionine-labeleri in vitro translated
ADA2, ADA3, and GCNS proteins (Fig. Lfi) w as exam ined 'Fig.
lO - As shown in Fig. 1C, second row, G ST-ADRl-TAD II could
bind the ADA2 protein. ADA2 did not bind control proteins
GST and GST-Vpu, nor did it display significantly increased
binding to GST-ADRl-TAD I, III, or IV (Fig. lO . In control
experim ents, in vitro translated luciferase w as incubated with
each o f the GST-ADRl-TADs and GST, and no binding to any
o f these fusions was observed (Fig. l O . In vitro translated
ADA3 did not bind to any o f the four GST-ADRl-TADs 'Fig. 1C,
third row). In contrast, in vitro translated GCN5, w hile inca
pable o f binding to GST alone, did bind to all four GST-ADRlTADs (bottom row). GCN5, however, did not display binding to
other GST-fusions such as GST-CAFl or GST-Vpu (bottom
row). For ADA2 binding to TAD II and GCNS binding to each of
the TADs, generally about 1-5% o f the input radioactivity was
retained by the GST-TADs (data not shown/.
The stability of binding o f ADA2 and GCN5 to A D R l TADs
was further tested by determ ining the effect o f increasing salt
concentrations on each of th ese interactions. As shown in Fig.
2, the binding between GST-ADRl-TAD H and ADA2 was
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Table m
Effect of the ada2 and gcnS alleles on ADRl activation of the ADH2-lacZgene

3-Galactosiriase activities (units/mg) represent the average of at least three separate transformants measured in the isogeme strains PSY316
(wild type>, PSY316-ada2 (ada2), and the strain GMY26 fgen5) as described (9). Each of these strains earned either the ADCY4 reporter piassud
'ADH2-iacZ) or the LG6S9Z (CYCl-lacZ) reporter (7). ADCY4 and LG699Z are identical except for the upstream sequences controlling the CYCI
TATA region in front of the LacZ gene. Strains were grown in minimal medium lacking uracil and containing 2% each of glycerol and ethanol DR)
or 8% glucose >Ri. S.E. values were less than 15%. ND, not done.
Reporter gene

Wild type

Scram

ada2

unta/mg
ADH2-lacZ
CYCl’lacZ

PSY315
PSY316

1.8
12

290
640

Table EV
The effect of ada2 and gcnS alleles on ADH2 expression

ADH II
OR

R
mtlliuntU/mg

Wild type
ada2
gcno
adrl
ADRI-S*
ADR1-5* ada2
sptIO
sptIO ada2

2600
970
310
10
ND
ND
ND
ND

<5
<5
<5
<5
150
64
85
110

R

xuuixtmg

ADH tl enzyme activities were conducted as described under “Exper
imental Procedures.* Strains were grown either on 8%glucose (R) or 3%
ethanol (DR). Wild type, strain 612-ld; ada2, isogenic to 612-ld except
ada2: CRA3; gcno, segregonts from croas-EGYl88-gl (gcnS) and 612ld-6a; adrl, data taken from Re£ 9. ADRl-5* ada2, and ADRl-5*
segregants were from crcss-612-Ld-al(tida2) and 787-6b (ADRl-o^r,
sptIO ada2, and sptlQ segregants were from cross-612-ld-al <ada2)
and l005-2-3b (sptIO). For the wild-type segregants from crossEGYlSfi-gl and 612-ld-6a. ADH Q enzyme activities ranged from 2000
to 2700 milliunitsfxng. ADH II activities were the average of at least
four separate determinations for individual strains or the average of at
least three segregants. SB . values were less than 20%.
Relevant genotype

gcno

DR

stable to sa lt concentrations up to 1.2 m KAc. Similarly, the
binding betw een GST-ADRl-TAD IV and GCN'5 was relatively
insensitive to increasing salt concentrations (Fig. 2). GCNS
binding to A D R i TADs 1 .11, and III was also stable a t high salt
concentrations (Fig. 2). These results suggest th at the depend
ence o f A D R l TAD activation on the ADA2 complex w as the
result o f specific A D R l TAD interactions with GCN5 and
ADA2.
Binding o f GCNS to ADRI TAD IV Deletion Derivatives Cor
relates with Their Ability to Activate Transcription.—D eletion
a nalysis o f ADRI suggested a fourth possible activation dom ain
in the C-term inal 642-1323 region (9). We have subsequently
show n th a t LexA-ADRl-<642-704) is capable of activating
transcription o f a LexA-lacZ reporter plasmid (Table II and Fig.
3A). T h is region was confirmed as important to full-length
ADRI function, since deletion o f residues 642-704 reduced
LexA-ADRl activation o f a LexA-lacZ reporter gene by 16-fold
(Table V) w ithout affecting LexA-ADRl abundance (data not
show n). Moreover, deletion o f TAD IV from the wild-type ADRI
at its chromosomal locus reduced ADRI ability to activate
ADH2 b y 20-fold (Table V). TAD rV has also been shown to be
absolutely required for peroxisomal function in the utilization
o f o leate (5). Because TAD rV appears to be especially impor
tan t for A D R I function, we characterized TAD IV further a s to
its regions im portant for activation and binding to GCNS.
C -term inal deletions o f LexA-TAD IV were assayed for th eir
ability to activate a LexA-lacZ reporter gene (Fig. 3A). All
deletion derivatives were expressed to comparable extents In
y east (d ata not shown), indicating that differences in protein
stability w ere not th e cause o f the differences in activity. LexAADRl-<642-704), -(642-701), and 4642-698) retained sign ifi

1.5
2.5

DR
unutimg

6.3
290

ND
ND

0.45
430

cant transcriptional activity, w hereas LexA-ADRl*<642-694>
and sm aller derivatives were less active.
To determine i f these differences in LexA-TAD IV derivative
activation abilities were a potential consequence o f their ability
to interact w ith GCN5, GST fusion proteins o f the TAD IV
deletion derivatives were constructed, and their ability to bind
w ith radiolabeled GCN5 w as analyzed. All o f the GST-TAD rV
derivatives were expressed to comparable extents (Fig. 3B.
bottom row). The ADRI-(642-704), AD R l 4642-701), and
ADRl-<642-698) moieties, which had the greatest activation
abilities (Fig. 3A), displayed the strongest binding to GCN5
(Fig. 33, top row). The rem aining derivatives displayed reduced
binding to GCN5 and reduced ability to activate. These data
show th at the activation strength of ADRI TAD IV derivatives
correlates directly with that o f their binding to GCN5 (see
Fig. 3A).
TADs I and IV of ADRI Bind Specifically to TFIIB —The
observation that a gcno or ada2 disruption resulted in only
partial blockage of ADRI activation o f ADH2 (Table IV) sug
gested th at ADRI w as interacting w ith factors in addition to
the ADA2 complex. Because it is known that transcriptional
activators can make contacts to several different cofactors and
core transcriptional components, we analyzed further whether
ADRI TADs could bind the transcriptional factor TFIIB. Incu
bation o f in vitro translated yeast TFIIB with GST-ADRl-TAD
fusions demonstrated that TAD I and to a lesser extent TAD IV
could retain TFTIB (Fig. 4). In vitro translated TFIIB. in con
trast, did not display significant binding to GST alone, GSTVpu, GST-TAD II, or GST-TAD IH (Fig. 4). TFIIB was able to
bind about 5-fold better to GST-TAD II than to GST alone but
only about 2-fold better than to GST-Vpu, suggesting that this
interaction between TAD II and TFIIB may not be significant.
The binding o f TFIIB to TADs I and IV was also stable to high
salt w ashes (1.2 m KAc) (data not shown). The region of TAD EV’
th at w as capable o f binding TFIIB was analyzed using the
series o f GST-TAD IV variants described above. Deletions of
TAD IV th at reduced its activation function (Fig. 3A) similarly
reduced its binding to tF IIB (Fig. 3B). As shown with GCNS
binding to these TAD IV deletion variants, the correlation
betw een TAD IV activation ability and binding to TFIIB was
nearly exact (Fig. 3A).
The region o f TFIIB that interacted with TAD I and TAD rV
was localized using the in vitro binding assay in order to
further exam ine the specificity o f this interaction. The C-terminal h a lf o f TFIIB (residues 135-345; was found to retain the
ability to bind to both TADs I and IV, whereas the N-terminal
segm ent o f TFIIB (residues 1-134) did not bind GST-TADs I or
IV (Fig. 5). In contrast to TFIIB, TBP displayed little or no
increased binding to GST-ADRl-TADs I or IV as compared
w ith the control GST-Vpu (Fig. 4). TBP also did not bind TAD
HI and interacted with TAD H only about 2-foid better than the
GST-Vpu control. These data suggest that TFIIB may be an
additional factor through which ADRI acts.
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Fig. 2. Stability o f TAD binding to ADAS and GCNS to high salt
washes. After binding of radioactive proteins to GST-TADs as descnbed in Fig. I. different wash conditions were used. The number*
refer to the concentration (in mM) of KAc used in the wash buffer. Bound
proteins were eluted with boiling and detected with fluorography fol
lowing SDS-PAGE.

COOMASSIE
S
©

GST

i

*

BINDING
FlC. I. Binding o f ADRI TADs to ADA2 and GCNS. A, Coomaasustained GST-TAD fusions. GST fusions were induced as described
;3Q). bound to glutathione-agaroae beads, and eluted from glutathioneagamse beads by boiling and separation by SDS-PAGE. Fifty Mg of
GST-TAD fusion is represented in each lane. GST-TAD 1 contains
residues 1-262 of ADRI; GST-TAD H contains residues 262-359; GSTTAD HI contains residues 420-462; and GST-TAD IV<r»nrains residues
642-701. B, in vitro translated proteins. T7 fusion proteins were trans
lated in uitro with ["Slmethiomne as described under “Sxpenmental
Procedures.” One al of radioactive proteins was separated by SDSPAGE and identified following fiuorography. C, binding of in vitro
translated proteins to GST-TAD fusions bound to glutathione-agarose
beads. Forty id of in vitro translated proteins were incubated with 50 Mg
of GST fusions and, after washing, eluted by boiling. Similar results
were obtained when bound proteins were eluted with excess glutathi
one. In general, a protein was considered to bind specifically if at least
15-20-fold more radioactive protein was retained by the GST-TAD th«p
by the GST-Vpu control and 20-40-fold more than for GST as observed
in at least three separate in vitro binding analyses. Densitoxnemc
analysts using an EC-210 densitometer was used to quantitate relative
intensities of bound proteins. Top row, binding of radioactive luciferase
to GST and GST-TADs; second row, binding of ADA2 to GST, GST-Vpu,
and GST-TADs; third row, binding of radioactive ADA3 to GST and
GST-TADs; bottom row, binding of radioactive GCNS to GST, GST-Vpu,
GST-CAFl. and GST-TADs.
DISCUSSION

activate a LexA reporter system. Individual LexA-TAD fusions
were nearly com pletely blocked for activation when either the
ADA2 or GCNS gene was deleted. Other LexA-transactivators
such as LexA-GCN4 have also been shown to function at re
duced levels w hen components of the ADA2 complex are de
leted (17, 34). In contrast, LexA fusions such as LexA-HAP4 are
aeariy fully transcriptionally active in die absence o f compo
nents o f the ADA2 complex (17). Full-length ADRI, when fused
to LexA, also displayed a 20-30-fold reduction in activation
function when components o f the ADA2 complex were defec
tive. The observation that LexA-ADRl (full-lengthi retained a
substantial, albeit reduced, function suggests that the activa
tion domains in full-length LexA-ADRl in th is context m ust
also be capable o f binding targets in addition to the ADA2
complex.
Several other cofactors known to be required for ADH2 de
repression w ere sim ilarly investigated in their requirement for
LexA-ADRl-TAD function. Defects in components of the SN'F'
SWT complex had essentially no effect on A D R i activation of
the LexA-lacZ reporter in contrast to their sizable reduction m
LexA-GAL4 activation of the same reporter gene (36). The
CCR4 and CAF1 transcriptional regulatory factors th at form a
multisubunit complex reduced LexA-AD RI -TAD function gen
erally about 2-3-fold (22, 23). This dependence on CCR4 and
C A Fl appears, however, to represent an indirect requirement,
since in vitro binding assays have been unable to substantiate
any specific interaction between ADRI TADs and CCR4 or
C A Fl (23) and since ccr4 and cafl can affect ADH2 expression
independent of ADRI activity (19, 22). Core transcriptional
factors may represent other potential targets for ADRi :see
below).
The ADRI activation of transcription of the ADH2lacZ re
porter w as also severely reduced by defects in the ADA2 com
plex. In addition, ada2 and gcno deletions reduced the ability o f
ADRI to activate zheADH2 gene at its chromosomal location.
These results confirm the importance o f the ADA2 complex in
A D R l activation. Yet, the fact that an ada2 or gcno disruption
does not give th e sam e ADH2 phenotype as an ADRI deletion
highlights the fact that at the ADH2 locus ADRI must also be
capable o f m aking additional contacts to activate transcription.
It should be noted that the effect of ada2 or gcno deletions on
A D R i activation ability was more severe when the reporter
gene (either LexA-lacZ or ADH2-lacZ) was on a high copy
plasmid than w hen it w as positioned in the chromosome (the
ADH2 locus). The cause of this difference is unclear, although
the plasmid-borne promoters and the chromosomal promoter
m ay differ in term s o f chromatin structure or in assem bly of
ADA2 complex-dependent transcription complexes.

TheADA2 Complex Mediates ADRI Activation—ADRI is the
primary transcriptional activator o f the ADH2 gene and has

Physical Interaction of ADRI TADs with Components of the
ADA2 Complex—Each o f the ADRI TADs could selectively bind

been shown previously (9) and herein to contain four separable
dom ains capable o f activating transcription. These individual
activation domains were found to be highly dependent on a
functional ADA2 complex for their ability as LexA fusions to

components o f the ADA2 complex. ADA2 interacted with TAD
II and GCNS w ith each o f the TADs. These interactions appear
specific for several reasons. First, for the interactions o f GCN5
and ADA2 to the ADRI TADs to be considered significant, at

89

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

32364

A D R I Contacts ADA2, GCNo, a n d TFIIB

LexA-ACRI-TADfVJmmm

>giiat»-iitoe

Remr*

teaw

jc s w y

b u d in f to

a n d itta

^ tn iJ

GCNS

TFIIB

LexA-ADRl 6 C -7 U

190

3*

17

LexA-ADRl 6*2-701

19

12

LexA-ADRl 6*2*691

15
70

24

10

LexA-ADRl 6*2-694

!S

4.1

LexA-ADRl 6*2-692

20

*0

LexA-ADRl 6*2-637

24

1.6

1

LexA-ADRl 6*2-679

Reievanc genotype

1

LexA-ADRl 6*2-675

t.7

LexA

Table V
77i« effect of a TAD TVdeletion art ADRI activation
ADH n activities were conducted aa described in Table IV. 3-Gaiactosidase activities were determined as described in Table IT in strain
EGY1S8. S Z values were less
15%. LexA-ADRl and LexA-ADRlA642/704 represent LexA-1-202 fused, respectively, to the full-iength
ADRI protein and the full-length protein whose residues 542-704 have
been deleted. ADRi and ADR1-A642/704 were expressed to comparable
extents in. vivo •'data not shown). ADRI. strain 40-iC..4DRl-A642-rO*f.
same as 40-lC except adrl-l ADR1-&542-704-7RP1.
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Fig. 4. TFIIB a n d TBP b in d in g to GST-TADs. Binding of ui utro
translated and radiolabeled TFIIB and TBP to GST-fusion proteins was
conducted as described in Fig. 1.
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Fig. 3. TAD IV activ atio n ab ility correlates w ith bind in g to
GCN5 a n d TFIIB. A, effect on LexA-ADRl 4642-704) transcriptional
activity by C-terminal deletions. LexA-ADRl-'642-704) and its deletion
derivatives were derived as described under ‘Experimental Proce
dures.* Each derivative was expressed to a comparable extent in yeast
strain EGYISS os analyzed by Western analysis (data not shown;.
3-GaIactosidase activities represent averages of at least three separate
transformants and were assayed as described in Table IL S.E. values
were less than 20%. The LexA reporter was p!84G in all cases. Relative
binding to GCN5 or TFIIB compares the amount of radiolabeled GCNS
or TFIIB bound to the GST-ADRl-TAD IV derivative with the amount
bound to GST alone. Data for relative binding was obtained following
densitometnc analysis of the data displayed in B. B, the effect of
C-terminal deletions of LexA-ADRl-* 642-704) on its ability to bind
GCN5 or TFIIB. GST-ADRl-TAD IV derivatives of length as indicated
in die figure were expressed in E. coli and bound to glutathione-agarose
beads as described under ‘‘Experimental Procedures/ The bottomrow is
a Coomaasie 31ue-stained SDS-PAGE separation of 50 Mg of m
*rh of
these proteins and illustrates the relative abundance of each of the
GST-denvatives used for binding. The top row displays the binding of
GCK5 to each of the GST-derivatives as analyzed by SDS-PAGE and
fluorography, whereas the middle row displays the binding of TFIIB to
each of the GST- derivatives.
le a st 20-fold more GCN5 or ADA2 had to be retained by the
GST-ADRl-TAD constructs than by th e GST and GST-Vpu
controls (See legend to Fig. I). In m any cases, up to 30-40-fold
more GCN5 was bound to the target th an to the controls: e.g.
GCNo binding to GST-ADRl-TAD IV and GST-ADRl-TAD OI.
Second. GCN5 failed to bind other GST fusions such as GSTVpu and GST-CAFl. ADA2 also failed to bind well to TAD I. Ill,
or IV. Each o f the significant bindings o f an ADRI TAD to
ADA2 or GCX5 was, moreover, shown to be stable even under
high sa lt w ash conditions. T his result su ggests that these con
tacts are not solely dependent on ionic interactions. Finally, the
GST-ADRl-TADs, w hereas th ey could bind ADA2 or GCN5,
failed to bind a number of radioacrively labeled proteins includ
ing luciferase. AD A3, C A Fl, CCR4, TBP, and N-TFHB.

Fig. 5. The C term inus of TFIIB binds to TADs I and IV of
ADRI. Binding studies between GST fusion proteins and radiolabeled
TFIIB fragments were conducted as described in Fig. I. [npuz repre
sents Cl/13] of C- or N'-TFIIB used in die binding reaction. C-TFIIB
contains residues 135-345 of TFUB. and N'-TFIIB contains residues
1-135 fused to GST. respectively.
The observation that each o f the ADRI TADs ana the fulllength ADRI are dependent on a functional ADA2 com plex for
maximal activation suggests that the physical interaction ob
served betw een the individual ADRI TADs and the ADA2 and
GCN5 proteins represents a physiologically significant interac
tion. This im plication is further supported by the TAD IV
deletion studies. Progressive C-terminal deletions of TAD IV
reduced TAD IV ability to activate and to directly interact with
GCN5. The correlation between TAD IV activation and its
ability to bind GCN5 w as nearly exact, suggesting biological
relevance for th e GCN5-TAD IV interaction.
T he C-terminal region o f TAD IV (residues 695-704, EYDYEHYQIL), w hich w as required for TAD IV function and
binding to GCN5, is rich in acidic and bulky hydrophobic amino
add s. The residues important for transcriptional activation
have been analyzed for several other activators, and hydropho
bic residues have increasingly been shown to be cru cal for
activation function f3 8 -4 0 ). T he hydrophobic residues in the C
terminus o f TAD IV m ay be sim ilarly used for providing con
tacts or a particular secondary structure that interacts with
transcriptional factors. However, the actual region of contact
m ay be complex, sin ce even derivative LexA-ADRl-(642-679)
retained some transcriptional activity (Fig. 3A).
In view o f th e recent identification of GCN5 as a histone
acetyltransferase, our results su ggest that ADRi recruits the
ADA2 complex, resulting in increased histone acetylation. Such
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ical r e a d in g of the m a n u s c rip t by S. B e rg e r a n d T. Y oung is also g re a tly
acetylation would presumably relax the a u d eosom al structure
a p p re c ia te d .
a t the promoter and facilitate nudeosom al rearrangement.
Since, upon derepression, ADRI is required a t th e ADH2 pro
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